Next Article in Journal
Comparative Evaluation and Physicochemical Characterisation of Three Tolerant Interspecific Grape Cultivars
Previous Article in Journal
Genetic and Morphological Analyses of Native Vanilla Populations in Mexico Call into Question the Taxonomy of V. odorata
Previous Article in Special Issue
Evaluation of Nutraceutical Properties of Fruits Derived from Some Wild-Growing Plant Species (Sambucus nigra L., Rubia tinctorum L., Phytolacca americana L. and Sambucus ebulus L.)
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Ocimum gratissimum: Chemical Composition, Phytochemical Properties, Antioxidants, and Pharmacological Activities: A Review

by
Nhlanhla Maphetu
1,
Jeremiah O. Unuofin
1,*,
Adewale O. Oladipo
2 and
Sogolo L. Lebelo
1
1
Department of Life and Consumer Sciences, College of Agriculture and Environmental Sciences, University of South Africa, Private Box X06, Florida 1710, South Africa
2
UNISA Biomedical Engineering Research Group, Department of Mechanical, Bioresources and Biomedical Engineering, College of Science, Engineering and Technology (CSET), University of South Africa, Florida 1710, South Africa
*
Author to whom correspondence should be addressed.
Plants 2026, 15(11), 1662; https://doi.org/10.3390/plants15111662
Submission received: 26 March 2026 / Revised: 7 May 2026 / Accepted: 18 May 2026 / Published: 28 May 2026

Abstract

Ocimum gratissimum L. subsp., commonly known as African basil, is a native African medicinal plant that has been used for generations to address various health issues. These include colds, flu, diabetes, diarrhoea, pain and swelling, psychological disorders, malaria, inflammation, and infections caused by fungi and bacteria. In addition, African basil is abundant in vitamins and minerals and is mostly used to add flavour to dishes and soups in West African households. Studies have identified multiple bioactive compounds in this plant, such as alkaloids, polyphenols, triterpenes, steroids, fatty acids, esters, alcohols, essential oils, ketones, and aldehydes. Key bioactive constituents, essential oils like thymol and eugenol, are responsible for the pharmacological effects of Ocimum gratissimum. The diverse bioactive compounds give the plant a wide range of therapeutic properties, including antioxidant, cognitive-enhancing, antimicrobial, anti-inflammatory, analgesic, anticancer, antihypertensive, hepatoprotective, and organoleptic effects. Notable mechanisms of action include the PI3K/Akt, NRF-2, and NF-κB signalling pathways, free radical scavenging, and modulation of pro-inflammatory cytokines such as IL-1β, IL-6, and TNF-α. This review paper aimed to compile recent studies on the phytochemistry, medicinal uses, therapeutic activities, and molecular mechanisms of action of Ocimum gratissimum. Further studies are needed to better understand the effects of Ocimum gratissimum at the pathological and molecular levels.

1. Introduction

Africa is home to over 45,000 plant species, and over 5000 of these plants are used as medicinal plants [1]. Medicinal plants are key remedies to treating various ailments such as obesity, heart-related diseases, respiratory diseases, diabetes, cold and flu, kidney complications, infections, and diarrhoea, amongst others [2,3]. Over 4000 of the available medicinal plants belong to the Lamiaceae family in African countries [1]. One of these medicinal plants is the sacred plant, Ocimum gratissimum. According to [4], Ocimum gratissimum is regarded as a sacred plant because it is used during prayers as one of the essences by the Hindu religion.
The plant, Ocimum gratissimum, belongs to the family Lamiaceae (previously Labiatae), and genus Ocimum of the species gratissimum. Ocimum gratissimum L. subsp., is a perennial shrub plant that is regarded as native to most African countries, such as Western Africa, Central and Southern Africa [5,6]. According to [7] revealed that O. gratissimum is native to the Asian part of the world [7,8]. Some of the Asian countries where O. gratissimum is mostly found are Iran, Nepal, India, and Sri Lanka [9,10]. In India, the Hindi and Nepali-speaking population know O. gratissimum as Ram tulasi [11] and Vriddhutulsi and Nimma tulasi, respectively [12]. Additionally, the O. gratissimum is widely distributed in West, East and Southern African countries such as Nigeria, Ghana, Kenya, Uganda, Madagascar, and South Africa [6,10,13,14,15].
In South Africa, the O. gratissimum plant is distributed in different parts of the country, from the tropicals of KwaZulu-Natal to the inland provinces of Limpopo and Mpumalanga. According to the South African National Biodiversity Institute (SANBI), O. gratissimum is known to locals as Umbijazane, Umnandi, and Uqabukhulu in the Zulu language [16,17]. The native names referred to are predominantly in IsiZulu, as the plant is widely distributed in Mpumalanga and KwaZulu-Natal, where most people in these regions are of the Zulu nation [18]. In most English-speaking regions, the plant is known as wild basil [16], scent or leaf basil [19,20,21], while in other African countries and the global market, the O. gratissimum is known as the African basil [5,7,15].
O. gratissimum is known for its rich aromatic properties [22,23], which are derived from its leaf essential oils [24]. O. gratissimum is said to be a herbaceous plant [22], which is mostly appreciated for its magnificent beauty, with decorative and vegetative shiny leaves with blooming flowers [25]. The plant is known for its many medicinal uses and edible benefits.
For instance, folklorically, O. gratissimum leaves are used for culinary purposes in Nigeria by adding the plant as part of a salad, or by pouring the plant in a pot to create flavour in a cooked soup [19,26,27]. In addition, it is used for the treatment and management of various ailments, such as diabetes [22], cold and fever, cough, and bronchitis [28], stomach aches and stomach discomfort, epilepsy, nostrils, and abdominal pains [26,29]. Moreover, other uses of O. gratissimum include using the plant as a mosquito repellent [30] and for treatment of bacteria and ear infections [31]. According to Ugbogu, O. gratissimum is used traditionally in pain management treatment, and the infusion is used to relieve cough (antitussive) [32].
O. gratissimum has a wide range of therapeutic uses, such as antioxidants, anti-inflammatory, antibacterial, antimicrobial, antipyretic, antifertility, neuroprotective, cognitive enhancing, and anti-cardiovascular, amongst others [2,31,33,34,35,36]. For example, Alvarenga reported that the presence of essential oils in O. gratissimum leaves promotes aromatherapeutic properties [23]. Moreover, essential oils of O. gratissimum are said to contain a variety of subsequent bioactive compounds such as eugenol, thymol, and citral, which have antifungal and antiflatoxigenic properties [23,37]. Additionally, O. gratissimum has high contents of crude and essential oils, organic acids, terpenes and flavonoids, which have been investigated to treat sickle cell diseases [37]. Furthermore, the essential oils of O. gratissimum are referred to as Ocimum oils, thyme and clove oils. These oils have been reported to possess anti-inflammatory and antimicrobial properties [10,38]. Additionally, in another study, the leaves of the plant have been reported to contain amines, alkones, aromatic compounds and alkyl compounds [13].
Medicinal plants continue to offer numerous economic and health benefits, driving the demand for more sustainable and efficient therapeutic strategies. The development of modern pharmaceutical products depends on compounds originating from medicinal plants. Although review articles on Ocimum gratissimum have already discussed conventional medicinal plants and their general use, several often ignore the convergence of the plant characteristics and scientific validation. Unlike previous reviews, this work examines the data-driven properties of bioactive compounds found in Ocimum gratissimum, such as eugenol, essential oils, polyphenols, and vitamins. Interestingly, the structure–activity relationship governing pharmacological activities and molecular mechanism studies that modulate their medicinal properties, as well as the current knowledge gap relating to effective utilisation, were identified. In addition, the review provides a critical analysis of previous research and provides an updated overview of the ethnomedicinal uses, toxicity, phytochemistry, and pharmacological activities of the Ocimum gratissimum L. plant.

Methodology

Several online search engines were used to gather journal papers, dissertations, and reports. The computerised database used to gather information for this review paper includes BMC, Wiley, Taylor & Francis online, PubMed, ScienceDirect and Google Scholar. Dissertations and thesis documents were gathered from the National ETD portal of South African theses and dissertations. Keywords used to generate information were: O. gratissimum, O gratissimum, Ocimum gratissimum L., basil leaf, basil flower, ram talsi, African basil, African leaf, and holy basil, medicinal uses of, ethnological use of, pharmacological use, antioxidant properties of, pharmacological properties, phenolic, phytochemical, anticancerous, antidiabetic, antipyretic, antibacterial, antiviral properties, antifungal, antibacterial, toxicity and antifertility.

2. Plant Characteristics

The herbaceous shrub, O. gratissimum, is made of five structural components, which are the roots, branches, stem, leaves and flowers. These component characteristics are discussed as follows:

2.1. Roots

The O. gratissimum roots are characterised by a fibrous root, which thickens and deepens towards the ground [34]. They appear lighter in colour, exhibiting a brown colour with a smooth texture. According to Sharma, O. gratissimum roots, similarly to the stem and leaves, have a majority of the pharmacological therapeutic activities such as anti-inflammatory, antioxidant, antidiabetic properties [22,39,40], antiviral [2] and neuroprotective properties [20]. Some of the notable bioactive compounds reported from the root extracts include flavonoids, tannins, phenolics [22,39], ethers, ketones, and hydrocarbons [41]. Additionally, the root portion of the plant has been used to combat various ailments, including sedating children [12,34], nose blockages, abdominal pains, and ear infections [34]. Pandey and colleagues also highlight that the roots of the Ocimum plant species assist in improving physical and mental strength when ingested [42].

2.2. Branches

The O. gratissimum branches are characterised by a dense shape, greenish-brown colour and pubescent appearance [38,43]. The shrub O. gratissimum contains multiple branches on each plant, which usually grow up to 1 metre long [44,45]. Identified active compounds from the branch extract include saponins, tannins, phlobatannins [46], essential oils, and other minerals such as calcium, potassium and nitrogen [38,47]. The presence of the bioactive compounds allows the branch extracts to be useful in combating ailments such as fever, cold and flu, and bacterial and fungal infections [47,48]. Some researchers have stated therapeutic activities associated with branch extracts to include antibacterial, antifungal, antihypertensive and antioxidant properties [43,46,49,50].

2.3. Stem

O. gratissimum is characterised by a woody brown stem, which appears square and short [27,51]. The stem is short as it contains a shrubby structure and can grow up to 2–3 m long [27,52]. The perennial shrub stem appears to be pubescent in young growing trees, and the colour appears to be greener compared to other mature shrub trees [27,51,53]. The base of the stem is firm with the epidermis, which looks like peeling off the strip of its base [50].
The stem portion has been reported to be rich in essential oils, which are used to treat bacterial infection, candidiasis, haemorrhoids, inflammation and chest pains [7,54,55,56]. Some of the therapeutic activities investigated from the stem extract include insecticidal properties [56], antioxidants, antibacterial [51], and antiprotozoal [50]. Furthermore, O. gratissimum contains high levels of eugenol essential oil [56], limonene, linalool and camphor bioactive compounds [7,57].

2.4. Flowers

The African basil is characterised by blooming colourful flowers, which are often used in gardens across African and Asian homes [7,43,58]. O. gratissimum flowers are characterised by a cream-white colour and purplish colour [7,59]. Flower extracts have been reported to have a pungent smell [60]. Flowers appear to be attached to the lapping stem and arranged in whorls [7,61]. In some areas of the world, the flowers appear to be greenish-yellow with elongated racemes, positioned in the axis quadrangular, with dense hair [7,50]. The base of the flower is sessile and appears oval with a bract which is measured at about 3–12 mm and 1–7 mm long [50]. Additionally, the pedicels of the flower appear longer than the calyx, with the calyx being ovoid in shape and measured at 3–4 mm [7,57].
Flower extracts have been identified to contain a variety of pharmacological properties. For instance, in a study by [58], the O. gratissimum flowers were used as insect repellents. In other studies, antioxidants, antifungal, antibacterial, and ovoidal activities have been investigated [51,52,58,62]. Moreover, the O. gratissimum flower extracts have been vastly investigated as they are rich in essential oils. In one study, ref. [62] report findings of various essential oils from the flower including methyl ester, methyl eugenol, caryophyllene, and linoleic acid [62]. Additionally, some studies have found a prevalent bioactive compound, eugenol, which is responsible for many of the flower’s pharmacological and therapeutic activities [6,63,64,65].

2.5. Leaves

The O. gratissimum leaves are the most extensively researched part of the plant. The O. gratissimum leaves are characterised by their elliptic-ovate shape and arrangement of the two opposite growing leaves from the nodes. Additionally, they have a translucent texture, with serrated margins and share saw-like edges. The leaf base appears wedged in its shape and contains crenate margins, with the apex, which is more tapered and pointier. The O. gratissimum leaves grow up to 3–9 cm wide and 5–13 cm long, their colour is green, and with maturity it turns lime. The leaves are the source of the pungent camphoraceous smell of the plant.
O. gratissimum leaves have been documented to be used traditionally across the globe for different reasons. To indicate a few, the O. gratissimum leaf extracts have been used to treat respiratory infections, stomach and laxative concerns, and ear infections [66,67]. Leaves are also used as condiments to make flour and food due to the presence of minerals such as fibres and carbohydrates [8,68]. Other uses include the treatment of bacterial and microbial infections, diarrhoea, pneumonia, headaches, colds, and flu [23,67,68,69]. O. gratissimum leaves are a rich source of antioxidants, and have anti-inflammatory [23,70], antibacterial and anticancerous properties [71]. Furthermore, ref. [27] add that the plant has therapeutic properties associated with neuroprotective potential [27].
The variety of therapeutic properties available from the leaves is due to the presence of multiple bioactive compounds. Moreover, O. gratissimum leaves are essential oil rich, with some researchers indicating that the plant is the source of eugenol [6,27,62]. Other reported bioactive compounds from the leaves include alkaloids [67], tannins, saponins, flavonoids, steroids [23,62], anthraquinones, glycosides, and thymol [72,73]. Chanthavong et al. add that the O. gratissimum leaves contain amines, aromatic compounds, alkyl and alkanes [13]. Other bioactive compounds indicated include the presence of polyphenols [71], N-propylamine, vernomine, and piperamide [67].

3. Minerals and Nutrition

O. gratissimum is also a consumable, nutritionally rich plant. Various authors have reported diverse nutritional ways to consume and use it as a flavouring agent. For example, quantitative analysis of minerals shows that the presence of various minerals’ secondary metabolite constituents is significantly higher compared to the recommendations of the World Health Organisation (WHO) consumption values per kilogram concentration [74]. The identified minerals include magnesium (1.17 ± 0.537 mg/kg), zinc (0.20 ± 0.06 mg/kg), sodium (0.31 ± 0.049 mg/kg) and potassium (0.26 ± 0.077 mg/kg) [74,75]. Oyet and Chibor (2024) also researched the preference of spices among various participants, and the findings suggested that individuals preferred medicinal plant spices from the Ocimum plant, as they contained rich flavour and scent, mostly due to the presence of essential oils [47]. Subsequently, another study surveyed different individuals on creating nutritional recipes in treating malnutrition using medicinal plants, in which O. gratissimum was indicated as one of the most used plants due to its presence of minerals such as calcium, sodium, iron and zinc [76,77].
O. gratissimum leaves are a good source of food nutrients. Various analyses, including proximate and elemental analysis, identified the presence of different minerals [74,75,78]. They screened and investigated acetone, methanol, and aqueous extracts, which showed the presence of lipids, iodine, carbohydrates, crude fibres, fat, protein, sodium, potassium, zinc, iron, calcium, manganese, and magnesium, including ash [74,75,76,77,78]. Furthermore, the presence of crude fibre was linked to the potential to lower serum cholesterol levels and with therapeutic activities such as antihypertensive, constipation, and anticancerous effects [75]. Additional minerals identified in the leaf extracts included lower concentrations of lead and nitrogen [74,78].
Additional bioactive compounds identified from the O. gratissimum plant include vitamins, tannins, anthraquinones, terpenoids, flavonoids, glycosides, polyphenols, xanthoproteics, resins, steroids, triterpenes, fatty acids, esters, alcohols and oils. Many analysis techniques have been deployed to assess the presence of bioactive compounds, including the use of spectrophotometric assessments, gas and liquid chromatography, flame ionisation detection, and qualitative and quantitative phytochemical screening [77,79,80,81,82,83,84,85].

4. Bioactive Compounds of Ocimum gratissimum with Molecular Structures

O. gratissimum have a profusion of various bioactive compounds which have been extracted from the whole plant, including roots, stems or bark, leaves, and branches. For instance, in a quantitative analysis study, ref. [79] show the presence of various polyphenol bioactive compounds such as tannins, phenols and alkaloids extracted from a leaf extract using hot water as a concentration liquid. The results show the presence of total phenolics (8.47 ± 1.33 mg/g GAE), total tannins (7.84 ± 0.13 mg/g TAE) and total alkaloids at 2.70 ± 0.05 mg/g TAE. In comparison, another study using methanol and hydro methanolic leaf extracts showed total flavonoids [(methanol 151.90 μg/QE mg−1; hydromethanolic 15.77 μg/QE mg−1)], and total phenols [(methanol 63.05 μg/GAE mg−1; hydromethanolic 74.59 μg/GAE mg−1)], demonstrating the presence of various polyphenols [86]. Furthermore, such studies’ results demonstrate that the aqueous leaf extracts have higher concentrations of phenolics compared to tannins [79].
Subsequently, in other studies, the presence of these bioactive compounds, such as alkaloids, terpenes, phenols, flavonoids and tannins, were indicated in leaf extracts [29,45,79,87]. Furthermore, [86] conducted an in vitro phytochemical analysis of the aerial portion of the O. gratissimum using methanol and hydro-methanol as extracting agents through gas chromatography, and the results presented 51 active oil constituents [86]. These constituents include linalool (32.2%), 1,8-cineole (15.57%), geraniol (14.7%), and epi-a-cadinol (5.5%) [86].
Moreover, a recent review study conducted by [38] indicates that O. gratissimum‘s main source of phytochemical compounds is essential oils, which account for about 80% of the total discovered compounds from the whole plant [32]. The review further indicates that the main constituents are eugenol and thymol, which are mostly extracted from the stem and leaves of O. gratissimum [38,88]. In another study, an aqueous leaf extract was analysed and used to extract thymol compounds using the voltametric technique [72]. Thymol bioactive compounds were profusely extracted. Thymol is an essential bioactive compound responsible for various pharmacological activities, such as antioxidant, anti-inflammatory, antiseptic, antifungal, anticancerous, immune-regulatory functions and antimicrobial properties [80,89]. In another review study, various roots of Ocimum species, including O. gratissimum, were examined. The study identified the presence of rosmarinic acid from the root extracts as the main component of the polyphenol constituents [42]. Rosmarinic acid is an essential secondary metabolite which has medicinal therapeutic activities such as antibacterial, antifungal, and antiviral [42,90].
Moreover, a study conducted by [36], using the ethanol extract, found that the presence of flavonoid compound fraction alleviates the effects of oxidative stress and inflammation in male Wistar rats. Furthermore, the active secondary metabolites such as flavonoids, thymol, terpenoids, and eugenol were associated with the ability to block the synthesis of prostaglandins by first inhibiting the activity of cyclooxygenase enzymes and thereafter preventing fever [36,91]. In a later review study of O. gratissimum, various polyphenolic secondary metabolite constituents, such as tannins, phenolics, and flavonoids, were highlighted to have enzymatic inhibitory effects on enzyme activities and functions [80]. Moreover, these claims were investigated in a study by [92], which assessed the aqueous extract against penile and testicular tissues and discovered that the presence of these secondary metabolites, including polyphenols, contains inhibitory properties against the following enzymes: angiotensin I-converting enzyme (ACE), acetylcholinesterase (AChE), phosphodiesterase (PDE) and arginase [32,92].
In the following, the chemical structures and functions of each bioactive constituent are provided.

4.1. Vitamins

O. gratissimum is also a source of vitamins. In [3], it is highlighted that vitamins are important for providing nutritional value and other therapeutic effects [3]. Therapeutic effects associated with vitamins found in O. gratissimum include antioxidant activity that help improve the immune system, as well as effects on vision and reproduction [78]. Additionally, the presence of vitamin A is associated with improvement of the respiratory functions [93]. The presence of vitamins in O. gratissimum has been investigated in various studies such as [78,94,95]. The identified vitamins include ascorbic acid, niacin, thiamin, and riboflavin; see Figure 1 for chemical structures [94,96]. Vitamins A, C and E were reported to be present in the O. gratissimum leaf [75,78].

4.2. Alkaloids

Alkaloids, bioactive compounds, were identified in multiple studies [6,45,74,79,97]. Alkaloids are associated with various therapeutic activities such as anti-inflammation, neurogenerative activities and antioxidants [45,79]. O. gratissimum-identified alkaloid constituents include ephedrine [84], while ribalinidine and spartiene presence was noted in some of the studies [60,84,98,99]. Figure 2 shows the chemical structures of alkaloid constituents.

4.3. Polyphenols

O. gratissimum is a medicinal plant that is rich in polyphenols. It contains many bioactive compounds such as phenolic acids, phenols, flavonoids, tannins, and resins. Different therapeutic properties and functions of these polyphenols have been investigated. It has also been discovered that the presence of polyphenol bioactive compounds in O. gratissimum makes the plant less aversive and more effective in its therapeutic activities when treating various ailments [75,79,100]. Moreover, the presence of polyphenols makes the O. gratissimum a good source of antioxidants, as well as making it anti-inflammatory [61,75,79,101]. The presence of the various phenolic acids and phenols was identified in the O. gratissimum plant, including caffeic acid, chlorogenic acid, ellagic acid, gallic acid, Rosmarinic acid and sinapic acid; see Figure 3 for their chemical structures [32,62,99]. Additionally, salvigenin and methyl eugenol were identified [32,75]. Furthermore, L-caftaric acid, trans-ferulic acid [36,62,102] and L-chicoric acid presence was indicated in a study by [100]. Figure 4 illustrates phenolics chemical structures.
Other forms of polyphenols, the flavonoids, are present in O. gratissimum. Flavonoid constituents identified in O. gratissimum include Flavan-3-ol [84], Apigenin, Catechin, Epicatechin, Flavone, Flavanones, Kaempferol, Morin, Isothymusin, Naringenin [103], Luteolin, Quercetin, Rutin, Nepetoidin A, Quercitrin, Xanthomicrol, Nevadensin, Lutelion-7-O-Glucoside, Lutelion-5-O-Glucoside, Vicenin-2 (also known as Apigenin 6,8-di-C-glucoside), Cirsimaritin, Hymenoxin, and Kaempferol 7,4′-dimethyl [80,104,105]. Figure 5 illustrates the flavonoids’ chemical structures, and ethers were also quantified [62,75,84,99] alongside vitexin compounds [32].

4.4. Triterpenes and Steroids

Triterpenes and steroids were identified in O. gratissimum, including oleanic acid [97,106], ursolic acid, tormentic acid, and pomolic acid; see Figure 6 [32]. Moreover, α-amyrim and 4,22 stigmastadiene-3-one presence was identified in a gas chromatography study conducted by [49,107]. Furthermore, triterpenes were discovered to have therapeutic benefits associated with antidiabetic [32], anti-viral properties [106] and insecticidal activities [87]. Figure 6 illustrates the chemical structures of triterpenes and steroid constituents.

4.5. Fatty Acids and Esthers

Fatty acids, bioactive compounds in O. gratissimum, are associated with their impact on lipid metabolism, which was identified to improve the serum lipid profile of male albino rats [108]. Various metabolites associated with fatty acids were identified in a recent study and exhibit antibacterial properties [49]. The fatty acid constituents include: n-Decanoic acid, Tetradecanoic acid, Dodecanoic acid, n-Hexadecanoic acid, 9-Octadecenoic acid (Z)-, methyl ester, Oleic Acid, Ethyl 14-methyl-hexadecanoate, Octanoic acid, Myristic and palmitic acid, as illustrated in Figure 7 [45,49,85]. Figure 7 illustrates their chemical structures.

4.6. Alcohols

The presence of alcohol in O. gratissimum has been identified to have a variety of therapeutic benefits, including acting as a reducing agent [100]. Some of the therapeutic benefits of alcohol from O. gratissimum include antimicrobial activities and anti-inflammatory and insect-repellent properties [32]. O. gratissimum-identified alcohol constituents are carveol, cis-verbenol, 2,6-octadien-1-ol, and myo-inostol; see Figure 8 [45,85,107]. Furthermore, ref. [45] indicates the presence of phytol and trans-geranylgeraniol [45,109]. Other alcohol constituents include geraniol and Spathulenol [32] and bisabolol [110].

4.7. Ketones and Aldehydes

In a recent review study, a variety of ketones were identified to be present in O. gratissimum plant; the identified ketones include trans-thujone, umbellulone, camphor, and fenchone—see Figure 9 [32]. Additionally, 6-Methyl-5-hepten-2-one and Benzaldehyde, 2.5-bis-(trimethylsilyl)-oxy]- presence was found [81,85,111]. Low concentrations of aldehydes were found in the plant, and minor constituents found include cintronellal, citral and neral, see Figure 10 [32]. Figure 9 and Figure 10 below shows chemical structures of ketones and aldehydes, respectively.

4.8. Oils and Essential Oils

The presence of essential oil in the O. gratissimum gives the plant a strong aromatic scent [32]. O. gratissimus’ most attributed essential oils include thymol and eugenol [36,88,112,113]. Several studies highlight the pharmacological benefits of thymol and eugenol, including antioxidants, which demonstrate high free radical scavenging potential against different radicals and inhibit oxidative stress in cellular damage [75,79,100]. Additionally, the identified essential oils from O. gratissimum can be classified into 4 types of groups, namely: hydrocarbonated monoterpenes (Figure 11A,B), oxygenated monoterpenes (Figure 12), hydrocarbonated sesquiterpenes (Figure 13) and oxygenated sesquiterpenes (Figure 14) [23,47,57,114].
Hydrocarbonated monoterpenes identified from the O. gratissimum plant include: camphene, α-thujene, α-pinene, β-pinene, sabinene, β-myrcene (Figure 11A) and α- and β-phellandrene, δ-3-carene, limonene, α-terpinene, p-cymene, trans-β-ocimene and cis-ocimene, γ-terpinene, terpinolene, p-cymenene, and p-menthane-1,3,8-triene, (Figure 11B) [32,47,97,114].
Moreover, the oxygenated monoterpenes identified in O. gratissimum are associated with various pharmacological activities such as anti-inflammatory, antioxidant, anti-repellent and antinociceptive activities [32,36,79]. Oxygenated monoterpenes are described as complex compounds as they are characterised by oxygen-containing chemical structures, such as those similar to alcohol, ethers, phenol, and aldehydes [115]. Additional identified oxygenated monoterpenes of O. gratissimum include: 1,8-cineole, cis-sabinene hydrate, linalool, trans-sabinene hydrate, trans-thujone, citronellal, umbellulone, borneol, terpinen-4-ol, p-cymen-8-ol, α-terpineol (also referred to as alpha-terpineol), thymol methyl ether, estragole, p-cymen-7-ol, thymol and carvacrol; see Figure 12 [36,79,114].
Several hydrocarbonated sesquiterpenes are indicated to be present in the O. gratissimum plant. Hydrocarbonated sesquiterpenes are associated with various therapeutic benefits such as gastroprotective, immune-modulatory, antimicrobial, antioxidant, and hepatoprotective effects [36,79,97]. Some of the identified hydrocarbonated sesquiterpenes includes: α-copaene, β-elemene, β-copaene, β-caryophyllene, α-Trans-bergamotene, (Z)- β-farnesene, α-humulene, Allo-aromadendrene, γ-murolene, Germacrene D, β-trans-bergamotene, β-selinene, β-bisabolene, (Z,E)- α-farnesene, α-muurolene, δ-cadinene, and Elemol; Figure 13 illustrates their chemical structures [6,7,32,116].
Ref. [117] highlight the essence of oxygenated sesquiterpenes in a molecular docking study, in which they found the presence of the oxygenated sesquiterpene constituent compound caryophyllene oxide. The researchers discovered that caryophyllene oxide interacts and inhibits lipoxygenase and other inflammatory cytokines, such as interleukin-6 (IL-6), interleukin-1 (IL-1), and tumour necrosis factor-α (TNF-α) [117]. Subsequently, Zakariyah and colleagues highlight the therapeutic benefits of antibacterial agents in a study involving Nigrospora oryzae [49]. The identified oxygenated sesquiterpenes of O. gratissimum include: Caryophyllene oxide, 1,2-epoxydehumulene, 3,7-(11)-eudesmadiene, Spathulenol, T-cadinol and γ-eudesmol; see Figure 14 [5,7,9,32,33,52,118].

5. Structure–Function Activity Relationship

O. gratissimum contains multiple bioactive compounds formed from different structure groups such as essential oils and volatile and non-volatile secondary constituent compounds. The structure–activity relationship (SAR) of different bioactive compounds in O. gratissimum is determined by their functional groups and structural designs, which then determines the structure’s potency as antioxidant, cognitive enhancing, antimicrobial, anti-inflammatory agents [105]. The structures, functional groups, and designs of these bioactive compound constituents explain how O. gratissimum utilises complex phytochemical networks to interact with and target critical biological targets [117]. O. gratissimum has multiple SARs, such as phenolic compounds and antioxidants SAR, flavonoid SAR and membrane protection, antimicrobial and anti-inflammatory SAR, cognitive enhancement and phenols SAR. Table 1 represents the SAR of O. gratissimum bioactive compounds, the targeted biological sites and activity outcomes.
Furthermore, some of the O. gratissimum SAR insights are essential indicators of the role bioactive compounds play in regulating pharmacological activities. Some of the key insights include antioxidants’ efficiency, which relates to free radicals scavenging activities that depend on phenolic rings, such as alkyl groups, which act as electronic donors to boost antioxidant activity potency. -COOH has electron-withdrawing abilities [105]. Subsequently, some SARs are linked to modulating various pathways, such as suppressing survival signals linked to extracellular signal-regulated signal (ERK) in cancer cells and activating protective pathways and nuclear factor erythroid 2-related factor (NRF-2) in healthy cells [119,120]. Moreover, additional O. gratissimum SAR includes dual pathway inhibition, which involves constituents, such as thymol and eugenol, that inhibit lipoxygenase and cyclooxygenase pathways by preventing the effects of respiratory problems linked to bronchoconstriction [119].
Table 1. Structural–function activity relationship of O. gratissimum bioactive compounds.
Table 1. Structural–function activity relationship of O. gratissimum bioactive compounds.
Functional GroupBioactive ConstituentAssociated MechanismOutcomesReferences
Phenolic Hydroxyl (-OH) groupsEugenol and ThymolAct as hydrogen donors to fight and neutralise free radicalsPotent antioxidant activities.[105]
Hydroxyl-mediated Eugenol and LuteolinChanges membrane fatty acids and affects the cytoplasmic membrane and ATP leakagePotent antibacterial activity[60,121]
Alkyl-Hydroxyl groupThymol and CarvacrolStabilises phenoxy radicals by donating electrons, subsequently increasing electron densityIncreased antioxidant potency[105]
Methoxy mediationMethyl-eugenol and EugenolStabilises free radicals and increases hydrogen-donating potentialIncreases antioxidant capacity[105]
Catechol structures groupLuteolin and ApigeninMediates and promotes electron donation for free radicalsEnhances neuroprotection and strengthens membrane protection[122]
Beta-sheet binding structureRosmarinic acidInvolved in directly binding to the beta sheet structure of amyloid-beta oligomers and fibrils, which inhibits alpha–beta aggregationAnti-Alzheimer’s effects[105,123]
Phenolic ringsThymol and EugenolBlocks prostaglandin synthesis by binding to the COXAnalgesic and anti-inflammatory effects[117]
Nucleophilic-Cysteines interactionRosmarinic acid and EugenolTriggers NRF2 release by interacting with nucleophilic cysteine on the KEAP1 proteinActivates redox homeostasis[123,124]
Sesquiterpene structure groupsCaryophylleneMediates specific agonist for the CB2 endocannabinoid receptorsImmune modulator and anti-analgesic effects[121,125]

6. Pharmacological Activities

O. gratissimum’s pharmacological activities have been extensively researched and well-documented by different researchers and authors. The pharmacological activities of O. gratissimum are possible due to the vast availability of bioactive compounds such as essential oils, polyphenols, alcohols, ketones, aldehydes, fatty acids, esters, alkaloids and vitamins. These bioactive compounds are responsible for making O. gratissimum a medicinal plant with a variety of therapeutic properties that function in treating different ailments. O. gratissimum therapeutic properties include antioxidants [32,45,74,75], neuroprotection [36], enzyme effects [79,108], anti-inflammatory activities [36,39,60,100,126], anticancer, antidiabetic, antidiarrheal, antimicrobial and antinociceptive effects [32,45,74,79,87,117] amongst others.
The pharmacological properties are reported in different studies, which include in vivo, in vitro, comparative and systematic reviews, survey studies, and clinical trials [34,38,60,70,81,96,108,113,127,128]. Table 2 below indicates and summarises recent pharmacological studies of O. gratissimum.

6.1. Pharmacological Mechanisms

Most medicinal plants exhibit a variety of pharmacological properties because they are rich in bioactive compounds capable of treating various ailments [133,134]. The presence of bioactive compounds enables medicinal plants to possess unique traits, such as therapeutic effects, mediated by biochemical and pharmacological mechanisms [135]. These compounds influence physiological and molecular processes to mediate diseases. O. gratissimum has multiple pharmacological mechanisms, including nootropic, anti-convulsion, antioxidant, antimicrobial, anti-inflammatory, anti-antigenic, anticancerous, and anti-plasmodial effects.
O. gratissimum pharmacological effects are controlled by different cellular signalling pathways. Some of the molecular mechanisms highlighted in this review include COX, LP-1, PGE, PGHS, and IL-1β, IL-6, and TNF-α signalling pathways, as well as TP53, BAX and BAK modulations, and PGE2 and Ach. The highlighted signalling pathways are shared in various therapeutic and pharmacological activities. Figure 15 provides a comprehensive overview of the molecular mechanisms underlying the pharmacological and biological effects of O. gratissimum.

6.1.1. Antioxidants

O. gratissimum is rich in naturally derived compounds, including antioxidants. Antioxidants are synthetically produced compounds that play a role in inhibiting the reactions of free radicals, which would cause oxidative stress and degenerative diseases [28]. O. gratissimum antioxidants are key fixtures and contributors to an array of pharmacological activities. The underlying antioxidant therapeutic activities are exerted by different bioactive compounds. The presence of essential oils, thymol, flavonoids, terpenoids and alkaloids collaboratively provides O. gratissimum with antioxidant therapeutic effects. Other researchers, such as [60,77], indicate rutin and saponins as some of the bioactive compounds that contribute to the antioxidant pharmacological properties. For instance, O. gratissimum can neutralise free radicals. The presence of thymol in O. gratissimum mediates the ability to facilitate the scavenging molecular cycle. In one of the studies, it highlights the ability of O. gratissimum to scavenge DPPH; the study results confirmed the DPPH scavenging half-maximal concentration value to be 100.00 ± 0.00 µg/mL [22]. Another scavenging concentration was recorded at 4.84 ± 0.34 µmol TE 9−1 FW [22], while 88.8 ± 0.63 w/v% is recorded in [79].
Subsequently, another antioxidant pharmacological potential of O. gratissimum is reducing power, which includes donation of electrons to reduce oxidised mediators by converting Fe3+ to Fe2+ [79]. A study investigated the reducing power of O. gratissimum aqueous leaves at different concentrations (3–21 w/v%). The results ranged from 0.68 ± 0.01 to 1.67 ± 0.11 (from low to high concentration). Moreover, ref. [70,136] conducted a reducing power assay using various concentration levels (0.2–1 mg/mL) with the reducing power inhibition results of 0.2–0.4 nm [70]. In addition, ref. [113] conducted an investigation of O. gratissimum leaves and roots and conducted the FRAP test; the leaves’ results were 23.89 ± 00.73 mol TE g−1 FW, while roots resulted in 22.41 ± 1.05 mol TE g−1 FW. FRAP was conducted on aqueous extracts (2.94 ± 0.03 mg AAE/g) [113]. The previous studies’ results highlight the potential of O. gratissimum to convert free radicals to be less aversive and the potential to reduce oxidised mediators.

6.1.2. Cognitive and Memory Enhancement Potential: Nootropic Properties

In a review, ref. [60] explore the various effects of O. gratissimum on memory improvement and neuroprotective potential, which were investigated in various animals. According to a recent study, ref. [137] found that O. gratissimum leaves extract exhibited memory and learning enhancement effects, as evidenced by the animal demonstrating decreased transfer latency and improved step-down latency [60,138]. Furthermore, the review further explored the exposure of O. gratissimum in animal models, and the findings indicated that the plant has nootropic properties and potential in improving working memory. This is similar to a study conducted by [139], which highlights an improvement in working memory. Other studies showed improved development in spatial memory [60,129,138], and one other later study indicated an increase in long-term memory consolidation [138].
O. gratissimum has neuroprotective effects, which are highlighted in a few recent studies. For instance, Aduyi and colleagues highlight the ability of O. gratissimum on the impact of oxidative stress effects and inhibition of neuroinflammation [8,60,140]. Meanwhile, a different study explored the exposure of the O. gratissimum ethanol leaf extract against focal ischemia and reperfusion in male Wistar rats, which revealed the plant’s potential to impact and regulate the neurotropic factors, such as enhancing synaptic plasticity, regulation of mitochondrial function, enhancement of blood-barrier integrity, and gene expression potential, which subsequently activates the nuclear factor erythroid 2-related factor (NRF2) signalling pathway; ref. [129]. Figure 16 illustrates the molecular mechanisms of action from these studies.

6.1.3. Antimicrobial

In a review, ref. [38] highlights the antibacterial properties of O. gratissimum and the plant’s ability to inhibit microbial pathogens, including common bacterial strains such as Salmonella typhimurium, Escherichia coli (E. coli), and Staphylococcus aureus, which are associated with causing diarrhoea [38]. The review further highlights the assessment of O. gratissimum water leaf and indicated a minimum concentration variation of about 0.001–0.1% across the bacterial strains. In another study, ref. [85] investigated the antibacterial properties of the plant against various bacterial strains such as Escherichia coli, Salmonella typhi, Proteus vulgaris, Shigella flexneri, Citrobacter freundii, and Morganella morganii. The bacterial strains are associated with causing gastroenteritis. The study assessed the various O. gratissimum extracts, including ethanol extract, and compared their potency against bacterial inhibition. From this study, it is highlighted that ethanol extract demonstrated the highest inhibition zone of 29.67 ± 0.33 mm against E.coli [85]. Similarly, an O. gratissimum ethanol extract was studied and found to be more susceptible against the following bacteria: Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae and Candida albicans [141]. Additionally, the authors emphasised that the antimicrobial properties of O. gratissimum are expressed by the available abundance of bioactive compounds such as terpenoids, steroids, flavonoids, alkanoids, phlabotannins and tannins [141].

6.1.4. Anti-Inflammatory

Refs. [3,142] highlight that inflammation is a critical process which is needed to maintain and protect an organism’s body against pathogens [3,142]. O. gratissimum has been researched and documented to contain anti-inflammatory properties, which occur through various mechanisms. For example, some of O. gratissimus’ pharmacological activities in inflammatory management include inhibition of inflammatory mediators, regulation of inflammatory cytokines, and pain management. The anti-inflammatory mechanisms are promoted by some bioactive compounds, such as rosmarinic acid, essential oils, phenolics, flavonoids, and eugenol compounds [112,143].
For instance, O. gratissimum bioactive compounds, such as essential oils, play a major role in regulating and promoting essential inflammatory mediators and biomarkers, including the inhibition of cyclooxygenase (COX) through the inhibition of two enzymes involved in inflammation production, namely prostaglandin H synthase (PGHS) and lipoxygenase (LP-1) [110,144]. The study inhibition concentration values were measured to be at 125 µ/mL and 144µ/mL repetitively for the enzymes [110,144]. In a review study, ref. [60] unpack various studies highlighting the role of flavonoid and eugenol from O. gratissimum, which contain the potential to inhibit pro-inflammatory cytokines, including interleukin 1-β (IL-1β), interleukin-6 (IL-6) and tumour necrosis factor-α (TNF-α) [32,60,143]. Interleukins 1-8 and IL-6 were noted to be reduced in [5]; see Figure 16. In a similar study, the essential oil constituent of O. gratissimum leaf extract was found to decrease the baseline concentration of prostaglandin E2 (PGE2) by 46% when adjusted to a concentration level of 5–20 µg/mL [5].
The identified bioactive compounds, eugenol and flavonoids, contribute to the overall anti-inflammatory molecular mechanisms. Eugenol and flavonoids have the potential to prevent the upregulation of nuclear factor kappa B (NF-kB) in inflammatory conditions [145]. Ref. [145] further highlights that the transcription factor NF-kB modulates the production of pro-inflammatory genes, which are responsible for chemokines and the encoding of cytokines and related enzymes such as COX. The production of pro-inflammatory mediators elevates NF-kB activities to downregulate immune cell activation, which subsequently lowers inflammatory stress signal [145]. Eugenol and flavonoids have the potential to inhibit the production of cytokines. When a chemical cell stressor occurs, it activates NF-kB signal pathways. The therapeutic properties of eugenol and flavonoids collaboratively trigger various inhibitory molecules to inhibit NF-kB signal pathway. The different inhibitory molecules released include IkKα and IkKβ (Figure 17 shows the pathway). When the NF-kB pathway is activated, the NF-kB proteins, such as p65 and p50, undergo phosphorylation, which is later degraded. The inhibitory proteins are deactivated by the IkB kinase complexes. The IkB kinase complex is made up of the following molecules: IKK-α, IKK-β and IKK-y [145].

6.1.5. Anti-Analgesic

Some of the anti-inflammatory properties are associated with pain management. O. gratissimum plant extracts are linked to the management and treatment of pain and the demonstration of their antinociceptive properties. Various studies, such as those conducted by [60,81,110], have reviewed and detailed the application and molecular mechanisms of O. gratissimum and its role as an anti-analgesic applicable medicinal plant [60,81,110].
In a review study, ref. [137] reviewed various later and recent studies that found that the available bioactive compounds, such as eugenol, myrcene and essential oils, have the potential and ability to reduce neuroinflammation in mice studies [146,147,148,149]. Moreover, in a later study, Prabhu and colleagues reviewed O. gratissimum aqueous extract, which demonstrated anti-inflammatory properties when subjected to agar-induced tests in male Wistar rats. The study showed that O. gratissimum extract has significant similarity to the actions of phenylbutazone [110]. While the anti-inflammatory properties of the O. gratissimum are attributed to the availability of bioactive compounds from the plants, O. gratissimum is a rich source of bioactive compounds, as indicated and illustrated in Figure 1, Figure 2, Figure 3, Figure 4, Figure 5, Figure 6, Figure 7, Figure 8, Figure 9, Figure 10, Figure 11, Figure 12, Figure 13 and Figure 14. Bioactive compounds that contribute to analgesic effects include eugenol and polyphenols [60], thymol, myrcene [81], β-caryophyllene, rosmaric acid, caffeic acid [84], and phenolic compounds such as flavonoids, tannins, saponins [77,84].

6.1.6. Anticancerous

Cancer is linked to about 9.8 million individual deaths each year worldwide [3]. Several researchers have investigated medicinal plants’ anticancer properties, including the use of O. gratissimum. One of the studies details that O. gratissimum leaf extract has anticancerous properties, by exhibiting cytotoxicity towards cancerous cells [13]. Furthermore, another study utilising the O. gratissimum leaf aqueous extract had an effect in decreasing cell apoptosis with the concentration value of 0.2 mg/mL when treating human hepatocellular carcinoma cell lines [119]. Moreover, another study adds that cell apoptosis occurred as the available bioactive compounds in O. gratissimum increased oxidative stress and had an effect on mitochondrial membrane potential loss [13,119].
Additionally, the pharmacological mechanisms of O. gratissimum on chemopreventive effects are mainly attributed to their potent antioxidant activities. For example, O. gratissimum phenolic compounds, such as flavonoids, phenols, alkaloids and saponins, contain modulative effects on lipid peroxidative [79]. Lipid peroxidation is responsible for and involved in the development of carcinogenesis. Ref. [150] add that the antioxidant properties of O. gratissimum, mediated by bioactive constituents such as 2-1 isopropyl-5-methylphenol, have the potential to eliminate free radicals. The development of free radicals has the effect of causing oxidative damage to DNA, protein structure, and lipids [151]. O. gratissimum has demonstrated potential in scavenging free radicals such as DPPH, peroxide and nitric oxide [41,118]. Furthermore, it has been noted that O. gratissimum bioactive compounds have potential in reducing oxidative stress, which leads to cell protection against carcinogenesis [79]. Moreover, the development of chronic inflammation is associated with a risk factor for the development of cancer [152]. O. gratissimum contains anti-inflammatory properties which are capable of inhibiting and modulating lipid peroxidation [79].
The ability to regulate and modulate anticancerous properties is facilitated by several bioactive compounds, such as terpenes and terpenoids [81,99]. Terpenes and terpenoids have the potential to inhibit tumour growth, induce cell apoptosis and exhibit cytotoxic effects towards cancerous cells [153].
O. gratissimum has anticancer therapeutic potential mediated through the phosphoinositide-3 kinase/protein kinase B (PI3K/Akt) signalling pathway. The PI3K/Akt signalling pathway is an essential biochemical switch that regulates cell proliferation, survival and growth [154]. Eugenol and flavonoids are key bioactive compounds that attenuate the PI3K/Akt signalling pathway [60]. These bioactive compounds inhibit Akt signalling activation, which subsequently prevents metastatic progression. In addition, activation of PI3K/Akt triggers pro-apoptotic mechanisms. For instance, when PI3K/Akt is suppressed, caspases 3, 8 and 9, which are regulatory enzymes that destroy cancerous cell structures, are activated. This suppression also leads to upregulation of pro-apoptotic genes, including TP53, BAX and BAK, and downregulation of anti-apoptotic genes, such as BCL-xL and BCL-2 [60,155].

6.1.7. Anti-Hypertensive and Vasorelaxant

Eugenol, essential oils, and rutin are some of the key bioactive compounds that contribute to the pharmacological activities of O. gratissimum, including antihypertensive and vasorelaxant effects [110,156,157]. The pharmacological activities of antihypertensives are associated with vasodilation. Vasodilatation is a body process involving the relaxation of the smooth muscle in the vascular wall. Subsequently, vasodilation is an essential response of smooth muscles to maintain homeostasis by distributing and facilitating oxygen to tissues as the demand grows [158]. O. gratissimum antihypertensive activity was researched in a study [157]. The study investigated whole-plant extracts, including leaves, stems, and flowers, by extracting bioactive compounds with aqueous extracts and treating hypertensive rats with the plant extracts. The study further indicates vasorelaxant effects in spontaneously hypertensive rats, lowering blood pressure and heart rate. Additionally, angiotensin-converting enzyme (ACE) activity was inhibited, and ACE levels were reported to decrease [157].
Moreover, vasodilation is a key effector of hypertensive mechanisms. A review by [60] highlights the recent and later studies, which were conducted in vivo. The review highlights one study that utilised O. gratissimum leaf extract at 1–20 mg/kg dose in mice, which has shown antihypertensive potential by exhibiting a dose-dependent decline in the mice, further increased mean aortic pressure and reduced heart rate of O. gratissimum extract-treated mice [60,159]. Additionally, in another later study, which is highlighted in a review conducted by [110], they highlight the function and role of calcium blockages. The review suggests that the calcium blockages are facilitated by the calcium influx. This potential is demonstrated by a study that utilised O. gratissimum essential oil from the aerial portion of the plants as extracts treated on salt hypertensive rats; the study compared the induced extract group and propranolol-treated rats. The O. gratissimum-treated rats demonstrated reversible hypotension, which was associated with vasorelaxant effects by removal of the vascular endothelium. Moreover, the study also highlights the effects of reduced calcium-induced contractions and blocking of plasmalemmal calcium influx released from the sarcoplasmic reticulum [156].

6.1.8. Hepatoprotective

O. gratissimum has hepatoprotective pharmacological potential. Hepatoprotective effects are plants’ ability to protect the liver by using their bioactive compounds, like phenols and essential oils, which exert protective effects, such as catalase, scavenging oxidative stress and removing toxins from the liver [160]. Some of the O. gratissimum hepatoprotective potential has been identified through various studies. For example, one study utilised the O. gratissimum leaf extracts by administering the extract to male albino rats induced with carbon tetrachloride (CCl4). The study demonstrated dose-dependent hepatoprotective effects of O. gratissimum; for instance, the concentrations that showed effects in male albino rats ranged from 200 to 600 mg/kg bw. Hepatoprotective effects observed include inhibition of oxidative stress and repair of liver damage. Observed improved hepato-markers concentrations included aspartate transaminase (AST) (90.3 ± 2.12 IU/L), alanine transaminase (ALT) (35.3 ± 4.34 IU/L), alkaline phosphatase (ALP) (40.2 ± 3.91 IU/L) and total bilirubin (TB) as 0.2–1.3 mg/dL [21].
Similarly, a study conducted in 2014 by [161] discovered that O. gratissimum hepatoprotective effects are dose-dependent; they treated male Wister rats induced with CCl4. The study highlights that the O. gratissimum extract-treated rats demonstrated liver damage restoration, decreased stenosis and fibrosis, all while increasing hepatises markers such as ALT, ASP, ALP and TB and inhibiting lipid peroxidation [161]. Subsequently, a study conducted by [119], which administered O. gratissimum extract to rats induced with hepatocarcinoma cells, show that the administered rats exerted hepatoprotective potential by increasing p/ERK 1 levels, which in turn triggered a survival signal for hepatocytes; see Figure 9 [32,119]. Meanwhile in a different study, root extracts of Ocimum plants were found to exert hepatoprotective effects by inducing lipid peroxidation, liver transaminase and malonaldehyde [42]. Moreover, ref. [162] add that Ocimum species can induce pro-inflammatory cytokines such as IL-1β, IL-6, TNF-α, and modulate oxidative stress. Figure 18 provides an overview of the molecular mechanisms by which O. gratissimum protects the liver.

7. Conclusions and Future Studies

O. gratissimum is a medicinal plant that has been traditionally used to address a variety of health issues. It is known for its effectiveness against bacterial and fungal infections, as well as its ability to alleviate inflammatory conditions such as pain and swelling. Additionally, it has been used in treating gastrointestinal problems such as indigestion, gastroenteritis, and diarrhoea. In other uses, this plant has also been utilised to manage metabolic disorders like diabetes. Moreover, the plant has other traditional applications in treating psychological conditions, including depression and anxiety. The O. gratissimum plant is also valued for its organoleptic properties, such as enhancing the flavours of various African dishes, particularly in West African nations like Nigeria, and creating edible meals to fight malnutrition in African countries.
The variety of bioactive compounds present in O. gratissimum enables the plant to have many therapeutic activities. Different kinds of phytochemical mass spectrometry profiling, such as gas chromatography and liquid chromatography, have helped researchers quantify and discover a variety of bioactive compounds. Among these, O. gratissimum is known to be a source of essential oils and vitamins, most of which are extracted from its leaves. Furthermore, alkaloids, phenols, fatty acids and alcohols are some of the important bioactive compounds contributing towards the therapeutic effects of O. gratissimum. Additionally, O. gratissimum is associated with a variety of essential oil clusters such as hydrocarbonated monoterpenes, oxygenated monoterpenes, hydrocarbonated sesquiterpenes and oxygenated sesquiterpenes. Moreover, essential oils make up the plant’s aromatic distinctive smell. Thymol, a volatile essential oil, is one of the bioactive constituents which is responsible for a variety of therapeutic activities. Subsequently, additional nonvolatile bioactive compound constituents include rosmaric acid, apigenin and luteolin, which are essential in contributing towards anti-inflammatory and antimicrobial potential.
O. gratissimum therapeutic potential activities have been discovered through different kinds of studies conducted in vivo or in vitro, which have demonstrated the potential effects bioactive compounds have on regulating biological, pharmacological and molecular mechanisms. Studies have shown that O. gratissimum has antioxidant potential, by scavenging free radicals such as DPPH, NO, and H2O2. Moreover, thymol constituent was discovered to be a key player in scavenging potential and in anti-inflammatory potential. The pharmacological and biological molecular mechanisms of O. gratissimum are primarily driven by its anti-inflammatory and antioxidant properties. The impact of these pharmacological properties ranges from modulating oxidative stress to activating p/ERK 1 levels, PI3K/Akt, and NRF2 signal pathways.
As a medicinal plant, Ocimum gratissimum is highly valued worldwide, particularly in Africa. The plant contains different bioactive compounds and vitamins which are essential in maintaining the body’s homeostasis. O. gratissimum, a medicinal plant, is a good source of vitamins and therapeutic benefits; further clinical studies are needed. Clinical studies can incorporate the effectiveness of various bioactive compounds of O. gratissimum to further assess their benefits in various therapeutic applications. Moreover, further studies on the molecular mechanisms of O. gratissimum are needed to elucidate the effects of its bioactive compounds at the molecular level.

Author Contributions

N.M., J.O.U., A.O.O. and S.L.L. wrote and designed the manuscript outline. A.O.O. and J.O.U., reviewed the manuscript. N.M. designed chemical structures using ChemDraw Version 23.11 for Microsoft and illustrated the molecular action pathways using BioRender.com. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Data Availability Statement

No new data were created or analyzed in this study. Data sharing is not applicable to this article.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. du Toit, A.; van der Kooy, F. Artemisia afra, a controversial herbal remedy or a treasure trove of new drugs? J. Ethnopharmacol. 2019, 244, 112127. [Google Scholar] [CrossRef]
  2. Bhattacharya, R.; Bose, D.; Maqsood, Q.; Gulia, K.; Khan, A. Recent advances on the therapeutic potential with Ocimum species against COVID-19: A review. S. Afr. J. Bot. 2024, 164, 188–199. [Google Scholar] [CrossRef]
  3. Maphetu, N.; Unuofin, J.O.; Masuku, N.P.; Olisah, C.; Lebelo, S.L. Medicinal uses, pharmacological activities, phytochemistry, and the molecular mechanisms of Punica granatum L. (pomegranate) plant extracts: A review. Biomed. Pharmacother. 2022, 153, 113256. [Google Scholar] [CrossRef]
  4. Lee, R. Vana Holy Basil Leaf, Ocimum gratissimum. uOttawa. 2023. Available online: https://www.uottawa.ca/research-innovation/jlholmes-mass-spectrometry-facility/chemical-facility/projects/hydrosol-project/rosehip-rosa-canina-vana-holy-basil-leaf-ocimum-gratissimum (accessed on 19 September 2024).
  5. Ezeorba, T.P.C.; Chukwuma, I.F.; Asomadu, R.O.; Ezeorba, W.F.C.; Uchendu, N.O. Health and therapeutic potentials of Ocimum essential oils: A review on isolation, phytochemistry, biological activities, and future directions. J. Essent. Oil Res. 2024, 36, 271–290. [Google Scholar] [CrossRef]
  6. Saran, P.L.; Damor, H.I.; Lal, M.; Sarkar, R.; Kalariya, K.A.; Suthar, M.K.; Damor, H.I.; Lal, M. Identification of suitable chemotype of Ocimum gratissimum L. for cost effective eugenol production. Ind. Crops Prod. 2023, 191, 115890. [Google Scholar] [CrossRef]
  7. Chukwuma, I.F.; Uchendu, N.O.; Asomadu, R.O.; Ezeorba, W.F.C.; Ezeorba, T.P.C. African and Holy Basil—A review of ethnobotany, phytochemistry, and toxicity of their essential oil: Current trends and prospects for antimicrobial/anti-parasitic pharmacology. Arab. J. Chem. 2023, 16, 104870. [Google Scholar] [CrossRef]
  8. Ademiluyi, A.O.; OAdemiluyi, A.O.; Ogunsuyi, O.B.; Akinduro, J.O.; Aro, O.P.; Oboh, G. Evaluating Water bitter leaf (Struchium sparganophora) and Scent Leaf (Ocimum gratissimum) extracts as sources of nutraceuticals against manganese-induced toxicity in fruit fly model. Drug Chem. Toxicol. 2023, 46, 236–246. [Google Scholar] [CrossRef]
  9. Ashokkumar, K.; Vellaikumar, S.; Murugan, M.; Dhanya, M.K.; Aiswarya, S.; Nimisha, M. Chemical composition of Ocimum gratissimum essential oil from the South Western Ghats, India. J. Curr. Opin. Crop Sci. 2020, 1, 27–30. [Google Scholar] [CrossRef]
  10. Ikeotuonye, C.; Uronnachi, E.; Nwakile, C.; Attama, A. Ocimum gratissimum essential oil: A review of extraction methods, phytochemical constituents, pharmacological uses and formulation approaches. J. Curr. Biomed. Res. 2023, 3, 1178–1196. [Google Scholar] [CrossRef]
  11. Rahman, N.; Borah, B.K.; Nath, T.; Hazarika, S.; Singh, S.; Baruah, A.R. Effective microbiocidal activity of Ocimum sanctum L. and Ocimum gratissimum L. extracts. Ann. Phytomed. Int. J. 2021, 10, 416–425. [Google Scholar] [CrossRef]
  12. Imosemi, I.O. A Review of the Medicinal Values, Pharmacological Actions, Morphological Effects and Toxicity of Ocimum gratissimum Linn. Eur. J. Pharm. Med. Res. 2020, 7, 29–40. [Google Scholar]
  13. Chanthavong, V.; Shrestha, B.; Thairat, S.; Srithavaj, T.; Thaweboon, S. Biological properties and active components of Ocimum. Asia-Pac. J. Sci. Technol. 2022, 27, 27. [Google Scholar]
  14. Kimuni, S.N.; Gitahi, S.M.; Njagi, E.M.; Ngugi, M.P. Antinociceptive potential of methanol leaf extracts of Cissampelos parreira (Linn), lantana camara (linn) and Ocimum gratissimum (african basil). J. Adv. Biotechnol. Exp. Ther. 2021, 4, 349–364. [Google Scholar] [CrossRef]
  15. Mollel, H.G.; Ndunguru, J.; Sseruwagi, P.; Alicai, T.; Colvin, J.; Navas-Castillo, J.; Fiallo-Olivé, E. African Basil (Ocimum gratissimum) is a reservoir of divergent begomoviruses in Uganda. Plant Dis. 2020, 104, 853–859. [Google Scholar] [CrossRef] [PubMed]
  16. von Staden, L. Ocimum gratissimum L. subsp. gratissimum. National Assessment: Red List of South African Plants Version. 2016. Available online: https://redlist.sanbi.org/species.php?species=1674-4003 (accessed on 19 September 2024).
  17. Schutte-Vlok, A.L.; Raimondo, D. Threatened Species Programme|SANBI Red List of South African Plants. National Assessment: Red List of South African Plants 2020.1. 2020. Available online: https://redlist.sanbi.org/species.php?species=1790-1 (accessed on 13 November 2021).
  18. Loth, C.-R. Recognition, Revitalisation, Regulation, Place Names and Indigenous Languages. In Proceedings of the 5th International Symposium on Place Names 2019; Loth, C.-R., Ed.; Sun Media Bloemfontein (Pty) Ltd.: Clarens, South Africa, 2020; pp. 1–262. [Google Scholar]
  19. Abu, M.L. A Review of the Efficiency of Ocimum gratissimum as a Vegetable Condiment. Afr. J. Agric. Food Sci. 2024, 7, 219–230. [Google Scholar] [CrossRef]
  20. Njan, A.A.; Olaleye, E.O.; Afolabi, S.O.; Anoka-Ayembe, I.; Gyebi, G.A.; Nyamngee, A.; Okeke, U.N.; Olaoye, S.O.; Alabi, F.M.; Adeleke, O.P.; et al. Identification of neurotherapeutic constituents in Ocimum gratissimum with cholinesterase and mono amine oxidase inhibitory activities, using GC-MS analysis, in vitro, and in silico approaches. Inform. Med. Unlocked 2023, 39, 101261. [Google Scholar] [CrossRef]
  21. Ansari, R.A.; Ansari, R.; Ak, A. Phytochemical analysis and hepatoprotective potential of aqueous leaf extract of Ocimum gratissimum (Scent leaf). J. Pharmacogn. Phytochem. 2021, 10, 192–195. [Google Scholar]
  22. Agunbiade, O.S.; Afolabi, O.B.; Jaiyesimi, K.F.; Adewale, O.B.; Okoh, P.O.; Adewole, E.; Mabayoje, S.O.; Agboola, E.K. Antioxidant capacities, antidiabetic potentials, and mineral compositions of pap aqua and aqueous extracts from Ocimum gratissimum L. J. Herbmed Pharmacol. 2024, 13, 43–51. [Google Scholar] [CrossRef]
  23. Alvarenga, J.P.; Silva, R.R.; Salgado, O.G.G.; Júnior, P.C.S.; Pavan, J.P.S.; Ávila, R.G.; Camargo, K.C.; Ferraz, V.; das Graças Cardoso, M.; Alvarenga, A.A. Variations in essential oil production and antioxidant system of Ocimum gratissimum after elicitation. J. Appl. Res. Med. Aromat. Plants 2022, 26, 100354. [Google Scholar] [CrossRef]
  24. Gilles, L.; Antoniotti, S. Chemical and Olfactory Analysis of the Volatile Fraction of Ocimum gratissimum Concrete from Madagascar. Chem. Biodivers. 2023, 20, e202300252. [Google Scholar] [CrossRef]
  25. Inegbedion, A.; Khadijat, A.I. Medicinal Potential of Ocimum gratissimum (Scent Leaf) and Vernonia Amygdalina Del (Bitter Leaf). Int. J. Innov. Res. Dev. 2022, 11, 90–93. [Google Scholar] [CrossRef]
  26. Mamita Kalita Devi, N.; Narzary, D. Ocimum gratissimum L. ssp. gratissimum var. macrophyllum Briq. (Lamiaceae: Nepetoideae: Ocimeae) a new record from northeastern India. J. Threat. Taxa 2023, 15, 24086–24091. [Google Scholar] [CrossRef]
  27. Udi, O.A.; Oyem, J.C.; Ebeye, O.A.; Chris-Ozoko, L.E.; Igbigbi, P.S.; Olannye, D.U. The effects of aqueous extract of Ocimum gratissimum on the cerebellum of male wistar rats challenged by lead acetate. Clin. Nutr. Open Sci. 2022, 44, 28–41. [Google Scholar] [CrossRef]
  28. Ashokkumar, K.; Pandian, A.; Murugan, M.; Dhanya, M.K.; Vellaikumar, S. Phytochemistry and pharmacological properties of Ocimum gratissimum (L.) extracts and essential oil—A critical review. J. Curr. Opin. Crop Sci. 2021, 2, 138–148. [Google Scholar] [CrossRef]
  29. Akindoyeni, I.O.A.O.; Oyeleye, I.S.; Ogunruku, O.O.; Oboh, G. Biofortification of scent leaf (Ocimum gratissimum L.) with selenium enhances antiinflammatory cytokines and humoral response in Wistar rats. J. Trace Elem. Miner. 2024, 8, 100128. [Google Scholar] [CrossRef]
  30. Idris, K.L.; Serdar, S.; Adeboye, S.E. Efficacy Evaluation of Ocimum gratissimum Stem Extract as Mosquito Repellent. Ilorin J. Sci. 2024, 11, 245–250. [Google Scholar]
  31. Adebesin, I.; Kolapo, K.; Amoka, S.; Olubunmi, O.; Olomoko, C.; Balogun, A.; Ganiyu, L. Phytochemical analysis and antibacterial efficacy of Ocimum gratissimum extracts on multi-drug resistant bacteria. Int. J. Med. Lab. Res. 2023, 8, 23–31. [Google Scholar] [CrossRef]
  32. Ugbogu, O.C.; Emmanuel, O.; Agi, G.O.; Ibe, C.; Ekweogu, C.N.; Ude, V.C.; Uche, M.E.; Nnanna, R.O.; Ugbogu, E.A. A review on the traditional uses, phytochemistry, and pharmacological activities of clove basil (Ocimum gratissimum L.). Heliyon 2021, 7, e08404. [Google Scholar] [CrossRef] [PubMed]
  33. Ojewumi, M.E.; Obanla, O.R.; Atauba, D.M. A review on the efficacy of Ocimum gratissimum, Mentha spicata, and Moringa oleifera leaf extracts in repelling mosquito. Beni-Suef Univ. J. Basic Appl. Sci. 2021, 10, 87. [Google Scholar] [CrossRef]
  34. Induar, S.; Parida, S.; Mohapatra, R. A complete overview of Ocimum Species: King of herbs Sadhni. Afr. J. Biol. Sci. 2024, 6, 2348–2369. [Google Scholar]
  35. Rahimi, M.; Mortazavi, M.; Mianabadi, A.; Debnath, S. Evaluation of basil (Ocimum basilicum) accessions under different drought conditions based on yield and physio-biochemical traits. BMC Plant Biol. 2023, 23, 523–538. [Google Scholar] [CrossRef]
  36. Chukwuemeka, C.B.; Orlu, N. Antipyretic and Anti-Inflammatory Effects of Ocimum gratissimum in Male Wistar Rats. S. Asian Res. J. Nat. Prod. 2023, 6, 28–38. [Google Scholar]
  37. Diyaolu, O.A.; Oluwabusola, E.T.; Attah, A.F.; Olori, E.O.; Fagbemi, A.A.; Preet, G.; Soldatou, S.; Moody, J.O.; Jaspars, M.; Ebel, R. Can Crude Oil Exploration Influence the Phytochemicals and Bioactivity of Medicinal Plants? A Case of Nigerian Vernonia amygdalina and Ocimum gratissimum. Molecules 2022, 27, 8372. [Google Scholar] [CrossRef]
  38. Pal, M.; Upadhyay, D.; Regassa, M.; Rabuma, T. A comprehensive review on antibacterial activity of Aloe barbadensis and Ocimum gratissimum against selected bacterial pathogens of public health concern. J. Adv. Microbiol. Res. 2024, 5, 88–95. [Google Scholar]
  39. Sharma, A.D.; Kaur, I.; Angish, S.; Thakur, A.; Sania, S.; Singh, A. Comparative phytochemistry, antioxidant, antidiabetic, and anti-inflammatory activities of traditionally used Ocimum basilicum L. Ocimum gratissimum L., and Ocimum tenuiflorum L. Biotechnologia 2022, 103, 131–376. [Google Scholar] [CrossRef]
  40. Wang, B.; Wang, Y.; Yuan, X.; Jiang, Y.; Zhu, Y.; Kang, X.; He, J.; Xiao, Y. Comparative transcriptomic analysis provides key genetic resources in clove basil (Ocimum gratissimum) under cadmium stress. Front. Genet. 2023, 14, 1224140. [Google Scholar] [CrossRef] [PubMed]
  41. Zhakipbekov, K.; Turgumbayeva, A.; Akhelova, S.; Bekmuratova, K.; Blinova, O.; Utegenova, G.; Shertaeva, K.; Sadykov, N.; Tastambek, K.; Saginbazarova, A.; et al. Antimicrobial and Other Pharmacological Properties of Ocimum basilicum, Lamiaceae. Molecules 2024, 29, 388. [Google Scholar] [CrossRef] [PubMed]
  42. Pandey, V.; Swami, R.K.; Narula, A. Harnessing the Potential of Roots of Traditional Power Plant: Ocimum. Front. Plant Sci. 2021, 12, 765024. [Google Scholar] [CrossRef] [PubMed]
  43. Chaachouay, N.; Bussmann, R.W.; Elachouri, M. Ocimum basilicum L. Ocimum gratissimum Lam. Lamiaceae. In Ethnobotany of Northern Africa and Levant; Springer: Cham, Switzerland, 2024; pp. 1–16. [Google Scholar]
  44. Imade, R.O.; Adesina Ayinde, B.; Alam, A. GC-MS Analysis and In Vitro Cytotoxic Effects of Ocimum gratissimum (Lamiaceae) Volatile Oil and Thymol on Cancer Cells. Pharm. Biomed. Res. 2023, 9, 115–124. [Google Scholar] [CrossRef]
  45. Egwuatu, I.A.; Anyanwu, E.G.; Ozoemena, C.L.; Ozor, C.C.; Ozoemena, O.F.; Obikili, E.N. Immuno-Protective Effect of Aqueous Extract of Ocimum gratissimum Leaf in Cyclophosphamide-Induced Myelotoxicity in Wistar Rat. J. Adv. Med. Med. Res. 2022, 34, 33–43. [Google Scholar] [CrossRef]
  46. Ugwu, M.N.; Asuk, A.A.; Dasofunjo, K.; Okafor, A.I.; Ujong, U.P. Phytochemical Screening of Methanol Extracts of Prosopis africana Seeds, Ocimum gratissimum and Vernonia amygdalina Leaves. J. Sci. Eng. Technol. 2022, 9, 112–119. [Google Scholar]
  47. Oyet, G.I.; Chibor, B.S. Potential Uses of Selected Indigenous Spices as Flavorants in Food Cream Formulations. Int. Inst. Acad. Res. Dev. 2024, 10, 81–97. [Google Scholar]
  48. Aumeeruddy, M.Z.; Mahomoodally, M.F. Global documentation of traditionally used medicinal plants in cancer management: A systematic review. S. Afr. J. Bot. 2021, 138, 424–494. [Google Scholar] [CrossRef]
  49. Zakariyah, R.F.; Ahmed, R.N.; Ajijolakewu, K.A.; Hamid, A.A. Enhanced Antibacterial Potential of Fractionated Bioactive Compounds Isolated from Endophytic Nigrospora oryzae UILRZ1 in Ocimum gratissimum. J. Trop. Biodivers. Biotechnol. 2025, 10, jtbb12019. [Google Scholar] [CrossRef]
  50. Akolkar, A.K.; Wankhade, A.; Wagh, N.S. A Review on Ocimum gratissimum. Int. J. Innov. Res. Technol. 2023, 9, 367–374. [Google Scholar]
  51. Monga, S.; Dhanwal, P.; Kumar, R.; Chhokar, V. Pharmacological and physico-chemical properties of Tulsi (Ocimum gratissimum L.): An updated review. Pharma Innov. J. 2017, 181, 181–186. [Google Scholar]
  52. Coulibaly, A.; Sawadogo, I.; Toé, M.; Hema, M.D.; Bationo, K.R.; Kiendrebeogo, M.; Nébié, C.R. Composition, Physico-Chemical and Antioxidant Properties of Ocimum gratissimum L. Essential Oil. J. Appl. Biol. Sci. 2023, 17, 486–499. [Google Scholar] [CrossRef]
  53. Guessan, B.Y.; Kiyinlma, C.; Diénéba, K.-B. Phamacognostic study of Ocimum gratissimum Linn.: Pharmafood plant. J. Pharmacogn. Phytochem. 2014, 2, 74–79. [Google Scholar]
  54. Fanou, B.A.; Klotoe, J.R.; Fah, L.; Dougnon, V.; Koudokpon, C.H.; Toko, G.; Loko, F. Ethnobotanical survey on plants used in the treatment of candidiasis in traditional markets of southern Benin. BMC Complement. Med. Ther. 2020, 20, 288–306. [Google Scholar] [CrossRef]
  55. Japhette, D.T.; Yimta, F.; Jonas, K.; Philippe, D.T.J.; Olivier, O.N.M.; Renaud, M.J.; Théophile, D.; Joseph, N.; Matchawe, C. Ethnobotanical survey of anti-hemorrhoidal plants in the Bamboutos division, West region of Cameroon. J. Pharmacogn. Phytochem. 2019, 8, 2287–2292. [Google Scholar]
  56. Liu, A.; Zhang, Y.C.; Qi, Y.T.; Wang, J.Z.; Wang, D.; Du, S.S. Chemical Characterization and Insecticidal Activities of the Essential Oils from the Different Parts of Ocimum gratissimum var. suave (Willd.) Hook. f. Chem. Biodivers. 2024, 22, e202401218. [Google Scholar] [CrossRef]
  57. Kumar, A.; Lal, R.K. The consequence of genotype × environment interaction on high essential oil yield and its composition in clove basil (Ocimum gratissimum L.). Acta Ecol. Sin. 2022, 42, 633–640. [Google Scholar] [CrossRef]
  58. Lun, X.; Jin, M.; Chen, Z.; Cao, Y.; Zhang, X.; Xu, X.; Li, Y.; Wang, H.; Zhang, Z. Flowering Ocimum gratissimum intercropped in tea plantations attracts and reduces Apolygus lucorum populations. Pest. Manag. Sci. 2024, 80, 4841–4852. [Google Scholar] [CrossRef]
  59. Rawat, R.; Tiwari, V.; Negi, K.S. A Comparative Study of Morphological and Anatomical Structures of Four Ocimum Species in Uttarakhand, India. J. Drug Deliv. Ther. 2016, 6, 1–6. [Google Scholar] [CrossRef]
  60. Udi, O.A.; Mega Oyovwi, O.; Adetomiwa Adeogun, E.; Oyovwi, M.O.; Adeogun, A.E. Exploring the cognitive-enhancing effects of Ocimum gratissimum: An ethnopharmacological and phytochemical review. Discov. Plants 2025, 2, 58. [Google Scholar] [CrossRef]
  61. Ganguly, S.; Kumar, J. Morphological analysis depicting different identifying features of Ocimum gratissimum L. Bangladesh J. Plant Taxon. 2025, 32, 231–237. [Google Scholar] [CrossRef]
  62. Nganteng, D.N.D.; Melong, R.; Mbiekop, E.P.; Maffo, T.; Allémann, É.; Delie, F.; Wafo, P.; Tchaleu, B.N.; Dzoyem, J.P. Chemical constituents and cytotoxic activity of Ocimum gratissimum L. S. Afr. J. Bot. 2022, 150, 330–333. [Google Scholar] [CrossRef]
  63. Rokonuzzaman, M.; Rahman, A.; Reza, A.; Liza, N.Y.; Okay, S.; Mostofa Jamal, M.A.; Demirtas, I. Comparative Analysis of Chemical Composition and Antibacterial Activities of Essential Oils from Two Ocimum Species. Antiinfect. Agents 2023, 22, 74–84. [Google Scholar] [CrossRef]
  64. Edo, G.I.; Samuel, P.O.; Ossai, S.; Nwachukwu, S.C.; Okolie, M.C.; Oghenegueke, O.; Asaah, E.U.; Akpoghelie, P.O.; Ugbune, U.; Owheruo, J.O.; et al. Phytochemistry and pharmacological compounds present in scent leaf: A review. Food Chem. Adv. 2023, 3, 100300. [Google Scholar] [CrossRef]
  65. Mal, S.; Dwivedi, A.R.; Kumar, V.; Kumar, N.; Kumar, B.; Kumar, V. Role of peroxisome proliferator-activated receptor gamma (PPARγ) in different disease states: Recent updates. Curr. Med. Chem. 2021, 28, 3193–3215. [Google Scholar] [CrossRef]
  66. De Garde, E.I.R.; Pavel, B.R.; Mambeke, M.H.; Arnaud Wilfrid, E.O.; Cyr Jonas, M.; Antoine, A.A. Evaluation of the Effect of the Aqueous Extract of the Recipe Made from the Leaves of Ocimum gratissimum. Linn (Lamiaceae) and Terminalia Superba Steam Bark. Engl (Combreataceae) on Loperamide-Induced Constipation. Int. J. Pharm. Pharm. Sci. 2023, 15, 19–25. [Google Scholar] [CrossRef]
  67. Okoye, C.I.; Adamu, B.B.; Abubakar, Z.I.; Idris, H.A.; Maidawa, G.L.; Mustapha, F.A.; Ayegba, S.O.; Abdallah, H.Y. Medical and Pharmacological Properties of Ocimum gratissimum (Scent Leaf): A Review. J. Health Metab. Nutr. Stud. 2024, 181. [Google Scholar] [CrossRef]
  68. Borooah, R.; Das, B.; Dutta Baruah, L.; Alam, S.; Saikia, A.; Das Purkayastha, M. Novel biscuits using whey protein and Ocimum gratissimum to mitigate protein burden: Quality parameters, in vitro protein digestibility, SWOT analysis and implication on public health. Food Humanit. 2024, 3, 100318. [Google Scholar] [CrossRef]
  69. Akbar, S. Ocimum gratissimum L. (Lamiaceae). In Handbook of 200 Medicinal Plants; Springer: Cham, Switzerland, 2020; pp. 1327–1338. [Google Scholar]
  70. Usunomena, U.; Eseosa, U. In vitro Medicinal Studies on Ocimum gratissimum Leaves. ARC J. Pharm. Sci. 2016, 2, 1–5. [Google Scholar] [CrossRef]
  71. Onyebuchi, C.; Kavaz, D. Effect of extraction temperature and solvent type on the bioactive potential of Ocimum gratissimum L. extracts. Sci. Rep. 2020, 10, 21760. [Google Scholar] [CrossRef] [PubMed]
  72. Lagnika, L.; Avosse, S.I.; Bouraima, F.O.; Sindedji, C.B.; Dakle, M.; Gueret, R.; Fort, L.; Gimbert, Y.; Napporn, T.W.; Zigah, D.; et al. Voltammetric techniques for low-cost on-site routine analysis of thymol in the medicinal plant Ocimum gratissimum. Talanta 2024, 269, 125411. [Google Scholar] [CrossRef] [PubMed]
  73. Sudan, P.; Sharma, M. Exploration of antifungal potential of extracts of leaves of Ocimum gratissimum against Microsporum gypseum. Res. J. Pharm. Technol. 2022, 15, 4908–4912. [Google Scholar] [CrossRef]
  74. Alexander, P. Phytochemical Screening and Mineral Composition of the Leaves of Ocimum gratissimum (Scent Leaf). Int. J. Appl. Sci. Biotechnol. 2016, 4, 161–165. [Google Scholar] [CrossRef]
  75. Igbinosa, E.O.; Uzunuigbe, E.O.; Igbinosa, I.H.; Odjadjare, E.E.; Igiehon, N.O.; Emuedo, O.A. In Vitro Assessment of Antioxidant, Phytochemical and Nutritional Properties of Extracts from the Leaves of Ocimum gratissimum (Linn). Afr. J. Tradit. Complement. Altern. Med. 2013, 10, 292. [Google Scholar] [CrossRef] [PubMed]
  76. Vissoh, A.C.S.; Klotoé, J.R.; Fah, L.; Agbodjento, E.; Koudokpon, H.; Togbe, E.; Saïdou, S.; Dougnon, V. Knowledge and practices of traditional management of child malnutrition and associated pathologies in Benin. J. Ethnobiol. Ethnomed. 2024, 20, 47–62. [Google Scholar] [CrossRef]
  77. Mgbemena, N.M.; Amako, N.F. Comparative Analysis of the Phytochemicals, Proximate and Mineral Compositions of Scent Leaf (Ocimum gratissimum) and Bitter Leaf (Vernonia amygdalina) Leaves. Int. J. Biochem. Res. Rev. 2020, 29, 1–9. [Google Scholar] [CrossRef]
  78. Moneme, E.; Nwaka, A.C.; Ajakpofo, F.O.; Anyanwu, O.R.; Onuegbu, M.E. Evaluation of Nutritional Composition of Ocimum gratissimum Leaf Extract. Int. J. Biochem. Res. Rev. 2024, 33, 415–419. [Google Scholar] [CrossRef]
  79. Enenebeaku, U.; Ahamefule, K.; Asiwe, E.; Ugenyi, A.; Iheme, P.; Eboh, O.; Iheanacho, G.; Opara, P. Exploring the phytochemistry and in vitro antioxidant potentials of hot water extract of Ocimum gratissimum (Scent Leaf). J. Pharmacogn. Phytochem. 2024, 13, 326–332. [Google Scholar] [CrossRef]
  80. Liu, S.; Lei, J.; Liu, H.; Chen, T.; Gao, C.; Luo, D.; Liao, Q.; Liu, X.; Chen, J.; Bonnave, M.; et al. Thymol: Properties, synthesis, mechanism of action, and applications. Front. Nutr. 2026, 13, 1774718. [Google Scholar] [CrossRef]
  81. Jaiswal, R.P.; Chugh, V.; Nagar, S.; Purwar, S.; Azam, A.; Verma, A. Screening of Metabolites and Metabolic Pathways in Five Different Ocimum Species from the Same Origin Using GC-MS. Biochem. Res. Int. 2025, 2025, 7121687. [Google Scholar] [CrossRef]
  82. Umoh, E.U.; Effiong, E.F. Comparative Phytochemical, Gc-Ms, Proximate, Minerals and Vitamins Composition of Gongronema latifolium and Ocimum gratissimum Leaf Extracts. S. Asian Res. J. Nat. Prod. 2024, 7, 227–240. [Google Scholar]
  83. Otavi, S.; Bharti, A.; Tekade, M.; Soni, S.; Mullick, P.; Saraf, S.; Saraf, S.; Tekade, R.K. Screening, Extraction, and Purification of Phytopharmaceuticals. In Coresource 4; CRC Press: Boca Raton, FL, USA, 2026; pp. 43–68. [Google Scholar] [CrossRef]
  84. Ajugwo, G.C.; Chukwura, E.I.; Ilikannu, S.O.; Chidozie, C.P. GC-FID Analysis of Ethanolic Leaf Extracts of Ocimum gratissimum L. Int. J. Res. Publ. Rev. 2024, 5, 1597–1603. [Google Scholar]
  85. Ogundoju, R.I.; Oladunmoye, M.K.; Babatunde, O.J. GC-MS profiling and antibacterial efficacy of Ocimum gratissimum (Linn.) against bacteria associated with gastroenteritis. Microbes Infect. Dis. 2025, 6, 873–884. [Google Scholar] [CrossRef]
  86. Zareiyan, F.; Khajehsharifi, H. In-vitro phytochemical analysis of essential oil and methanolic and hydromethanolic extracts of Ocimum gratissimum. J. Plant Biochem. Biotechnol. 2022, 31, 894–906. [Google Scholar] [CrossRef]
  87. Okwuonua, E.S.; Nnanna, C.E.; Nwankwocha, C.P.; Okoye, I.C. Pesticidal effects of scent leaf (Ocimum gratissimum L.) on maize weevil: Potency of scent leaf on Sitophilus zeamais. J. Biol. Res. 2023, 96, 11246. [Google Scholar] [CrossRef]
  88. Dambolena, J.S.; Zunino, M.P.; López, A.G.; Rubinstein, H.R.; Zygadlo, J.A.; Mwangi, J.W.; Thoithi, G.N.; Kibwage, I.O.; Mwalukumbi, J.M.; Kariuki, S.T. Essential oils composition of Ocimum basilicum L. and Ocimum gratissimum L. from Kenya and their inhibitory effects on growth and fumonisin production by Fusarium verticillioides. Innov. Food Sci. Emerg. Technol. 2010, 11, 410–414. [Google Scholar] [CrossRef]
  89. Peng, X.; Zhang, X.; Sharma, G.; Dai, C. Thymol as a Potential Neuroprotective Agent: Mechanisms, Efficacy, and Future Prospects. J. Agric. Food Chem. 2024, 72, 6803–6814. [Google Scholar] [CrossRef]
  90. Murugesan, R.; Vasuki, K.; Ramadevi, S.; Kaleeswaran, B. Rosmarinic acid: Potential antiviral agent against dengue virus—In silico evaluation. Intell. Pharm. 2024, 2, 528–539. [Google Scholar] [CrossRef]
  91. Batiha, G.E.S.; Alkazmi, L.M.; Wasef, L.G.; Beshbishy, A.M.; Nadwa, E.H.; Rashwan, E.K. Syzygium aromaticum l. (myrtaceae): Traditional uses, bioactive chemical constituents, pharmacological and toxicological activities. Biomolecules 2020, 10, 202. [Google Scholar] [CrossRef]
  92. Ojo, O.A.; Ojo, A.B.; Oyinloye, B.E.; Ajiboye, B.O.; Anifowose, O.O.; Akawa, A.; Olaiya, O.E.; Olasehinde, O.R.; Kappo, A.P. Ocimum gratissimum Linn. Leaves reduce the key enzymes activities relevant to erectile dysfunction in isolated penile and testicular tissues of rats. BMC Complement. Altern. Med. 2019, 19, 71. [Google Scholar] [CrossRef] [PubMed]
  93. Nnenne, S.K.; Ubaoji, K.I.; Ogbodo, U.C.; Enemor, V.H.A.; Oladejo, A.A. Comparative Study on the Nutritional and Antioxidant Components of Fruit Parts of Citrullus lanatus. Eur. J. Nutr. Food Saf. 2020, 12, 39–51. [Google Scholar] [CrossRef]
  94. Adeniyi, S.A.; Orjiekwe, C.L.; Ehiagbonare, J.E.; Arimah, B.D. Evaluation of chemical composition of the leaves of Ocimum gratissimum and Vernonia amygdalina. Int. J. Biol. Chem. Sci. 2012, 6, 1316–1323. [Google Scholar] [CrossRef][Green Version]
  95. Dharsono, H.D.A.; Putri, S.A.; Kurnia, D.; Dudi, D.; Satari, M.H. Ocimum Species: A Review on Chemical Constituents and Antibacterial Activity. Molecules 2022, 27, 6350. [Google Scholar] [CrossRef]
  96. Ekesiobi, A.O.; Iheukwumere, C.M.; Iheukwumere, I.H.; Ejike, C.E.; Ilechukwu, C.C.; Dim, C.N.; Ike, V.E.; Okereke, F.O.; Ochibulu, S.C. Natural Product-Based Therapies: Exploring the Potential of Ocimum gratissimum and Vitamin C Combination against Vibrio cholerae Infections. IPS Interdiscip. J. Biol. Sci. 2025, 4, 119–124. [Google Scholar] [CrossRef]
  97. Bhavani, T.; Mohan, R.R.; Nyamisha, J.; Krishna, A.G.; Prabhavathi, P.; Raja, R.; Baba, H.; Mohan, R.; Mounica, C. Phytochemical screening & antimicrobial activity of Ocimum gratissimum review. J. Pharmacogn. Phytochem. 2019, 8, 76–79. [Google Scholar]
  98. Ajayi, A.M.; Martins, D.T.O.; Balogun, S.O.; Oliveira, R.G.; Ascêncio, S.D.; Soares, I.M.; Barbosa, R.D.S.; Ademowo, O.G. Ocimum gratissimum L. leaf flavonoid-rich fraction suppress LPS-induced inflammatory response in RAW 264.7 macrophages and peritonitis in mice. J. Ethnopharmacol. 2017, 204, 169–178. [Google Scholar] [CrossRef]
  99. Olumide, M.D.; Ajayi, O.A.; Akinboye, O.E. Comparative study of proximate, mineral and phytochemical analysis of the leaves of Ocimum gratissimum, Vernonia amygdalina and Moringa oleifera. J. Med. Plants Res. 2019, 13, 351–356. [Google Scholar] [CrossRef]
  100. Anandachockalingam, A.; Shanmugam, R.; Ryntathiang, I.; Dharmalingam Jothinathan, M.K. Green Synthesis of Silver Nanoparticles Using Zingiber officinale and Ocimum gratissimum Formulation for Its Anti-inflammatory and Antidiabetic Activity: An In Vitro Study. Cureus 2024, 16, e58098. [Google Scholar] [CrossRef]
  101. Ullah, S.; Rauf, N.; Hussain, A.; Sheikh, I.A.; Farooq, M. HPLC profile of phenolic acids and flavonoids of Ocimum sanctum and O. basilicum. Int. J. Plant Based Pharm. 2022, 2, 205–209. [Google Scholar] [CrossRef]
  102. Ajayi, A.B.; Afolabi, B.M.; Ajayi, V.D.; Oyetunji, I.; Atiba, A.; Ehichioya, J.; Ibukun, B. Semen Parameters Associated with Male Infertility in a Sub-Saharan Black Population: The Effect of Age and Body Mass Index. J. Gynecol. Infertil. Cit. 2018, 1, 1–8. [Google Scholar]
  103. Dzoyem, J.P.; Nganteng, D.N.D.; Melong, R.; Wafo, P.; Ngadjui, B.; Allémann, E.; Delie, F. Bioguided identification of pentacyclic triterpenoids as anti-inflammatory bioactive constituents of Ocimum gratissimum extract. J. Ethnopharmacol. 2021, 268, 113637. [Google Scholar] [CrossRef]
  104. Ikokide, J.E.; Jaja, F.I.; Ajibade, T.O.; Oyagbemi, A.A.; Oyeyemi, M.O. Phytochemical analysis of polyphenol-rich extract of Ocimum gratissimum leaves by GC–MS, TFC, TPC, TTC, and in vitro antioxidant properties. Discov. Mol. 2025, 2, 24. [Google Scholar] [CrossRef]
  105. Vasincu, A.; Rusu, R.N.; Ababei, D.C.; Bulea, D.; Arcan, O.D.; Vasincu, I.M.; Beșchea Chiriac, S.; Popescu, I.R.; Bild, W.; Bild, V. The Neuroprotective Potential of Ocimum Plant Species: Seasoning the Mind with Sweet and Holy Basil. Nutrients 2025, 17, 2877. [Google Scholar] [CrossRef]
  106. Venuprasad, M.P.; Kumar Kandikattu, H.; Razack, S.; Khanum, F. Phytochemical analysis of Ocimum gratissimum by LC-ESI–MS/MS and its antioxidant and anxiolytic effects. S. Afr. J. Bot. 2014, 92, 151–158. [Google Scholar] [CrossRef]
  107. Chowdhury, T.; Goutam Kumar Basak Deepalakshmi, P.D.; Saha, S.; Mandal, A. Metabolomics using Gas chromatography-mass spectrometry and antibacterial activity of nine Ocimum taxa of Dakshin Dinajpur district, West Bengal, India. J. Appl. Nat. Sci. 2021, 13, 127–136. [Google Scholar] [CrossRef]
  108. Prince Ogochukwu, A.; Chinedu Paulinus, N.; Ngozi Kalu, A.; Precious Ulonnam, E.; Anthony Cemaluk, C.E.; Enyinna Wisdom, C.; Favour Junior, A.; Anthony Uchenna, O. Efficacy of methanol extract of Ocimum gratissimum in modulating prostate size, antioxidant activity, and histopathology in testosterone induced benign prostate hyperplasia in male albino rats. Univers. J. Pharm. Res. 2025, 10, 25–30. [Google Scholar] [CrossRef]
  109. Ingole, S.N. Phytochemical analysis of leaf extract of Ocimum americanum L. (Lamiaceae) by GCMS method. World Sci. News 2016, 37, 76–87. [Google Scholar]
  110. Prabhu, K.S.; Lobo, R.; Shirwaikar, A.A.; Shirwaikar, A. Ocimum gratissimum: A Review of its Chemical, Pharmacological and Ethnomedicinal Properties. Open Complement. Med. J. 2009, 1, 1–15. [Google Scholar] [CrossRef]
  111. Choudhary, M.; Gehlot, A.; Arya, I.D.; Arya, S. Influence of different auxin treatment on ex vitro rooting in in vitro regenerated micro shoots of Terminalia arjuna (Arjun). J. Pharmacogn. Phytochem. 2018, 7, 3079–3082. [Google Scholar]
  112. Ijinu, T.P.; Jacob, J.; Sreejith, S.L.; Parvathy, S.; Pushpangadan, P. Phytochemical Constituents and Pharmacology of Ocimum gratissimum L. In Bioactives and Pharmacology of Lamiaceae; Apple Academic Press: Palm Bay, FL, USA, 2023; pp. 367–388. [Google Scholar]
  113. Weeplian, T.; Somsong, P.; Tayjasanant, T.; Kiravittaya, S. Improving phytochemicals and antioxidant activity of clove basil (Ocimum gratissimum L.) with far-red and UV-A light supplementation in late production stages. Acta Hortic. 2025, 1, 277–284. [Google Scholar]
  114. Ajayi, R.O. Comparative Gas Chromatograph-Mass Spectrometer and Fourier Transform Infrared Profiling of Essential Oil from Ocimum gratissimum Harvested from Dumpsites in Three Local Government Area in Edo State. Bachelor’s Thesis, University of Benin, Benin City, Nigeria, 2025. [Google Scholar]
  115. Liu, N.; Li, J.; Liu, J.; Xu, K.; Ren, F.; Yao, X. Study on pyrolysis behavior of agricultural and forestry wastes using thermogravimetric-Fourier transform infrared spectrometer (TG-FTIR). Asia-Pac. J. Chem. Eng. 2024, 19, e3020. [Google Scholar] [CrossRef]
  116. Ojianwuna, C.C.; Enwemiwe, V.N.; Esiwo, E.; Aghahowa, E.; Ifeta, S.; Edhebe, P.; Oborayiruvbe, E.T. Efficacy of Essential Oils of Ocimum gratissimum and Mesosphaerum suaveolens Against Culex quinquefasciatus. Nat. Prod. Commun. 2024, 19, 1934578X241306949. [Google Scholar] [CrossRef]
  117. Olaoye, I.F.; Oso, B.J.; Aberuagba, A. Molecular Mechanisms of Anti-Inflammatory Activities of the Extracts of Ocimum gratissimum and Thymus vulgaris. Avicenna J. Med. Biotechnol. 2021, 13, 207. [Google Scholar]
  118. Tomar, H.; Rawat, A.; Nagarkoti, K.; Prakash, O.; Kumar, R.; Srivastava, R.M.; Rawat, S.; Rawat, D.S. Ocimum gratissimum L. and Ocimum sanctum L.: Comparative compositional analysis of essential oils and in-vitro biological activities with in-silico PASS prediction and ADME/Tox studies. S. Afr. J. Bot. 2023, 157, 360–371. [Google Scholar] [CrossRef]
  119. Huang, C.C.; Hwang, J.M.; Tsai, J.H.; Chen, J.H.; Lin, H.; Lin, G.J.; Yang, H.L.; Liu, J.Y.; Yang, C.Y.; Ye, J.C. Aqueous Ocimum gratissimum extract induces cell apoptosis in human hepatocellular carcinoma cells. Int. J. Med. Sci. 2020, 17, 338. [Google Scholar]
  120. Kao, S.H.; Chen, H.M.; Lee, M.J.; Kuo, C.Y.; Tsai, P.L.; Liu, J.Y. Ocimum gratissimum Aqueous Extract Induces Apoptotic Signalling in Lung Adenocarcinoma Cell A549. Evid. Based Complement. Altern. Med. 2010, 2011, 739093. [Google Scholar]
  121. Hao, P.M.; Quoc, L.P.T. Chemical profile and antimicrobial activity of Ocimum gratissimum L. essential oil from Dak Lak province, Vietnam. J. Plant Biotechnol. 2024, 51, 50–54. [Google Scholar] [CrossRef]
  122. Pradhan, D.; Biswasroy, P.; Haldar, J.; Cheruvanachari, P.; Dubey, D.; Rai, V.K.; Kar, B.; Kar, D.M.; Rath, G.; Ghosh, G. A comprehensive review on phytochemistry, molecular pharmacology, clinical and translational outfit of Ocimum sanctum L. S. Afr. J. Bot. 2022, 150, 342–360. [Google Scholar] [CrossRef]
  123. Taguchi, R.; Hatayama, K.; Takahashi, T.; Hayashi, T.; Sato, Y.; Sato, D.; Ohta, K.; Nakano, H.; Seki, C.; Endo, Y.; et al. Structure–activity relations of rosmarinic acid derivatives for the amyloid β aggregation inhibition and antioxidant properties. Eur. J. Med. Chem. 2017, 138, 1066–1075. [Google Scholar] [CrossRef]
  124. Onobrudu, D.A.; Acha, J.O.; Orororo, O.C.; Enudinisu, G.N.; Onyesom, I. A Study on Toxicity and Antimalarial Efficacy of Ocimum gratissimum, Influence on Lung Antioxidant Defense and Nrf2 Expression in Plasmodium Berghei (Nk65) Infected Mice. Biomed. Pharmacol. J. 2025, 18, 2474–2491. [Google Scholar]
  125. Usman, M.; Vadnere, G.P.; Jain, S.C.; Patil, D.; Patil, P. Extraction and Identification of Volatile Compounds from Ocimum gratissimum Using Gas Chromatography. J. Drug Deliv. Ther. 2025, 15, 89–95. [Google Scholar] [CrossRef]
  126. Pandey, A.K.; Tiwari, S.P.; Biswas, D.; Patel, Y.; Jajda, H.M.; Dave, G.S. Evaluation of Phytochemicals, Antioxidant and Anti-inflammatory properties of leaves of Ocimum basilicum L. Res. J. Pharm. Technol. 2023, 16, 1981–1986. [Google Scholar] [CrossRef]
  127. Remesh, A.V.; Babu, C.S.V. Insights on mitigation, fumigant persistence and oviposition deterrence of Callosobruchus chinensis using Ocimum gratissimum essential oil. Int. Biodeterior. Biodegrad. 2025, 201, 106048. [Google Scholar] [CrossRef]
  128. Masroor, H.; Shukla, S.; Pandey, S.; Israr, J.; Arshad, M.; Gupta, M. Ocimum gratissimum L. Leaves Extract Protects Osteoblast-Like Cells From Glucose-Induced Stress by Antioxidant Mechanisms and RUNX2 Signaling: A Combined Experimental and Computational Study. ChemistrySelect 2026, 11, e05053. [Google Scholar] [CrossRef]
  129. Bora, K.S.; Shri, R.; Monga, J. Cerebroprotective effect of Ocimum gratissimum against focal ischemia and reperfusion-induced cerebral injury. Pharm. Biol. 2011, 49, 175–181. [Google Scholar] [CrossRef]
  130. Onwudiwe, T.C.; Madubuogwu, N.U.; Ogbuagu, E.O.; Azudialu, B.C.; Ogbonna, P.C. Investigating the anticonvulsant potential of ethanol leaf extract of Ocimum gratissimum on experimental-induced convulsions in albino rats. J. Med. Plants Stud. 2025, 13, 18–23. [Google Scholar] [CrossRef]
  131. Bankole, B.M.; Bodjrenou, S.; Bodecker, J.; Noukpoakou, E.; Chadare, F.J.; Termote, C.; Amoussa Hounkpatin, W. Formulation of children’s nutrient-dense recipes from Adansonia digitata pulp and Ocimum gratissimum leaves in North Benin. NFS J. 2024, 35, 100176. [Google Scholar] [CrossRef]
  132. Onuoha, C.P.; Etim Iibehe, N.; Oguzie, E.E. Corrosion protection of mild steel in water-in-diesel emulsion using Ocimum gratissimum extract. Vietnam. J. Chem. 2025, 63, 40–48. [Google Scholar] [CrossRef]
  133. Shoaib, S.; Ansari, M.A.; Fatease, A.; Al Safhi, A.Y.; Hani, U.; Jahan, R.; Alomary, M.N.; Ansari, M.N.; Ahmed, N.; Wahab, S.; et al. Plant-Derived Bioactive Compounds in the Management of Neurodegenerative Disorders: Challenges, Future Directions and Molecular Mechanisms Involved in Neuroprotection. Pharmaceutics 2023, 15, 749. [Google Scholar] [CrossRef] [PubMed]
  134. Shi, L.; Zhao, W.; Yang, Z.; Subbiah, V.; Suleria, H.A.R. Extraction and characterization of phenolic compounds and their potential antioxidant activities. Environ. Sci. Pollut. Res. 2022, 29, 81112–81129. [Google Scholar] [CrossRef]
  135. Luther, J. Pharmacological Mechanisms of Medicinal Plants: Unlocking their Therapeutic Potential. J. Pharmacogn. Nat. Prod. 2024, 10, 3–4. [Google Scholar]
  136. Gava, J.S.; Simões, G.A.; Portes, D.B.; Cruz, J.V.; Maddaleno, A.S.; Vinardell, M.P.; Mitjans, M.; França, H.S.; Fronza, M. Nanoemulsification Enhances the Regenerative and Safety Profile of Ocimum gratissimum Essential Oil In Vitro. ACS Omega 2025, 10, 45596. [Google Scholar] [CrossRef]
  137. Akanbi, D.A.; Ogboriga, P.O.; Adeniyi, I.A.; Lawal, A.M.; Olusola, M.A.; Oluyemi, P.A.; Onasanwo, S.A. The neuroprotective effects of Ocimum gratissimum-supplemented diet on scopolamine-induced memory impairment in mice model of Alzheimer’s Disease. Phytomedicine Plus 2026, 6, 100979. [Google Scholar] [CrossRef]
  138. Thalla, S.; Tammu, J.; Thalla, S.R. Nootropic activity of Ocimum gratissimum in Streptozotocin induced Amnesia. Asian J. Res. Chem. 2012, 5, 1437–1439. [Google Scholar]
  139. Ouyang, X.; Wei, L.; Pan, Y.; Huang, S.; Wang, H.; Begonia, G.B.; Ekunwe, S.I.N. Antioxidant properties and chemical constituents of ethanolic extract and its fractions of Ocimum gratissimum. Med. Chem. Res. 2013, 22, 1124–1130. [Google Scholar] [CrossRef]
  140. Ajiboye, B.O.; Famusiwa, C.D.; Amuda, M.O.; Afolabi, S.O.; Ayotunde, B.T.; Adejumo, A.A.; Akindele, A.F.I.; Oyinloye, B.E.; Owolabi, O.V.; Genovese, C.; et al. Attenuation of PI3K/AKT signaling pathway by Ocimum gratissimum leaf flavonoid-rich extracts in streptozotocin-induced diabetic male rats. Biochem. Biophys. Rep. 2024, 38, 101735. [Google Scholar] [CrossRef]
  141. Ujong, U.; Okon, V.; Odom, G.; Igwe, C. The antimicrobial and phytonutrient profile of Ocimum gratissimum. GSC Biol. Pharm. Sci. 2021, 14, 045–050. [Google Scholar] [CrossRef]
  142. Mehta, S.; Sharma, A.K.; Singh, R.K. Pharmacological activities and molecular mechanisms of pure and crude extract of Andrographis paniculata: An update. Phytomed. Plus 2021, 1, 100085. [Google Scholar] [CrossRef]
  143. Ajayi, A.M.; Ologe, M.O.; Ben-Azu, B.; Okhale, S.E.; Adzu, B.; Ademowo, O.G. Ocimum gratissimum Linn. Leaf extract inhibits free radical generation and suppressed inflammation in carrageenan-induced inflammation models in rats. J. Basic. Clin. Physiol. Pharmacol. 2017, 28, 531–541. [Google Scholar] [CrossRef]
  144. Bedi Sahouo, G.; Tonzibo, Z.F.; Boti, B.; Chopard, C.; Mahy, J.P.; N’guessan, Y.T. Anti-inflammatory and analgesic activities: Chemical constituents of essential oils of Ocimum gratissimum, Eucalyptus citriodora and Cymbopogon giganteus inhibited lipoxygenase L-1 and cyclooxygenase of PGHS. Bull. Chem. Soc. Ethiop. 2003, 17, 191–197. [Google Scholar] [CrossRef]
  145. Habtemariam, S. Anti-Inflammatory Therapeutic Mechanisms of Isothiocyanates: Insights from Sulforaphane. Biomedicines 2024, 12, 1169. [Google Scholar] [CrossRef]
  146. Freire, C.M.M.; Marques, M.O.M.; Costa, M. Effects of seasonal variation on the central nervous system activity of Ocimum gratissimum L. essential oil. J. Ethnopharmacol. 2006, 105, 161–166. [Google Scholar] [CrossRef]
  147. Tanko, Y.; Magaji, G.M.; Yerima, M.; Magaji, R.A.; Mohammed, A. Anti-nociceptive and anti-inflammatory activities of aqueous leaves extract of Ocimum gratissimum (Labiate) in rodents. Afr. J. Tradit. Complement. Altern. Med. 2008, 5, 141–146. [Google Scholar] [CrossRef]
  148. Ferreira, O.O.; Kumar, R.; da Silva, L.R.R.; Mali, S.N.; Tambe, S.; Rosa, U.A.; Costa, L.S.; Lobato, L.G.N.; Botelho, A.D.S.; Karakoti, H.; et al. Phytochemistry, pharmacological insights, and food science applications of natural bioactive compounds from Ocimum species with a focus on essential oils. Food Front. 2025, 6, 2081–2107. [Google Scholar] [CrossRef]
  149. Rabelo, M.; Souza, E.P.; Soares, P.M.G.; Miranda, A.V.; Matos, F.J.A.; Criddle, D.N. Antinociceptive properties of the essential oil of Ocimum gratissimum L. (Labiatae) in mice. Braz. J. Med. Biol. Res. 2003, 36, 521–524. [Google Scholar] [CrossRef] [PubMed]
  150. Emeka, U.C.; Chikodi, N.; Mirian, N. Structure-activity relationship of a bioactive compound in Ocimum gratissimum. Int. J. Adv. Eng. Manag. 2021, 3, 1095–1098. [Google Scholar]
  151. Martemucci, G.; Costagliola, C.; Mariano, M.; D’andrea, L.; Napolitano, P.; D’Alessandro, A.G. Free Radical Properties, Source and Targets, Antioxidant Consumption and Health. Oxygen 2022, 2, 48–78. [Google Scholar] [CrossRef]
  152. Ogidi, O.I.; Omu, O.; Ezeagba, P.A. Ethno pharmacologically active Components of Brassica Juncea (Brown Mustard) Seeds. Int. J. Pharm. Res. Dev. 2019, 1, 9–13. [Google Scholar] [CrossRef]
  153. Logesh, R.; Alam, W.; Alsharif, K.F.; Albrakati, A.; Akkol, E.K.; Khan, H. Role of terpenes in regulating leukemia: Mechanistic and clinical updates. Minerva Biotechnol. Biomol. Res. 2024, 36, 130–143. [Google Scholar] [CrossRef]
  154. Seyed, M.A.; Ayesha, S.; Azmi, N.; Al-Rabae, F.M.; Al-Alawy, A.I.; Al-Zahrani, O.R.; Hawsawi, Y. The neuroprotective attribution of Ocimum basilicum: A review on the prevention and management of neurodegenerative disorders. Future J. Pharm. Sci. 2021, 7, 139. [Google Scholar] [CrossRef]
  155. Shenoy, T.N.; Abdul Salam, A.A. Therapeutic potential of dietary bioactive compounds against anti-apoptotic Bcl-2 proteins in breast cancer. Crit. Rev. Food Sci. Nutr. 2025, 65, 4915–4940. [Google Scholar] [CrossRef] [PubMed]
  156. Interaminense, L.F.L.; Jucá, D.M.; Magalhães, P.J.C.; Leal-Cardoso, J.H.; Duarte, G.P.; Lahlou, S. Pharmacological evidence of calcium-channel blockade by essential oil of Ocimum gratissimum and its main constituent, eugenol, in isolated aortic rings from DOCA-salt hypertensive rats. Fundam. Clin. Pharmacol. 2007, 21, 497–506. [Google Scholar] [CrossRef] [PubMed]
  157. Shaw, H.M.; Wu, J.L.; Wang, M.S. Antihypertensive effects of Ocimum gratissimum extract: Angiotensin-converting enzyme inhibitor in vitro and in vivo investigation. J. Funct. Foods 2017, 35, 68–73. [Google Scholar] [CrossRef]
  158. Moreno-Domínguez, A.; Colinas, O.; Arias-Mayenco, I.; Cabeza, J.M.; López-Ogayar, J.L.; Chandel, N.S.; Weissmann, N.; Sommer, N.; Pascual, A.; López-Barneo, J. Hif1α-dependent mitochondrial acute O2 sensing and signaling to myocyte Ca2+ channels mediate arterial hypoxic vasodilation. Nat. Commun. 2024, 15, 6649. [Google Scholar] [CrossRef]
  159. Singh, V.; Kahol, A.; Singh, I.P.; Saraf, I.; Shri, R. Evaluation of anti-amnesic effect of extracts of selected Ocimum species using in-vitro and in-vivo models. J. Ethnopharmacol. 2016, 193, 490–499. [Google Scholar] [CrossRef]
  160. Mitra, S.; Lami, M.S.; Uddin, T.M.; Das, R.; Islam, F.; Anjum, J.; Hossain, M.J.; Emran, T.B. Prospective multifunctional roles and pharmacological potential of dietary flavonoid narirutin. Biomed. Pharmacother. 2022, 150, 112932. [Google Scholar] [CrossRef] [PubMed]
  161. Chiu, Y.W.; Chao, P.Y.; Tsai, C.C.; Chiou, H.L.; Liu, Y.C.; Hung, C.C.; Shih, H.C.; Lai, T.J.; Liu, J.Y. Ocimum gratissimum is effective in prevention against liver fibrosis in vivo and in vitro. Am. J. Chin. Med. 2014, 42, 833–852. [Google Scholar] [CrossRef] [PubMed]
  162. Choubey, V.K.; Gupta, T.; Gogoi, R.; Tamang, R.; Sarma, N.; Begum, T.; Lal, M.; Dutta, D.; Perveen, K.; Khan, F.; et al. Chemical compositions and different biological activity of leaf essential oil of Ocimum americanum L. grown in acidic soil conditions. J. Essent. Oil-Bear. Plants 2023, 26, 1172–1184. [Google Scholar] [CrossRef]
Figure 1. Chemical structures of vitamin constituents in O. gratissimum.
Figure 1. Chemical structures of vitamin constituents in O. gratissimum.
Plants 15 01662 g001
Figure 2. Chemical structures of alkaloids in O. gratissimum.
Figure 2. Chemical structures of alkaloids in O. gratissimum.
Plants 15 01662 g002
Figure 3. Chemical structures of phenols acids in O. gratissimum.
Figure 3. Chemical structures of phenols acids in O. gratissimum.
Plants 15 01662 g003
Figure 4. Chemical structures of phenolics in O. gratissimum.
Figure 4. Chemical structures of phenolics in O. gratissimum.
Plants 15 01662 g004
Figure 5. Chemical structures of flavonoids in O. gratissimum.
Figure 5. Chemical structures of flavonoids in O. gratissimum.
Plants 15 01662 g005
Figure 6. Chemical structures of triterpenes and steroids in O. gratissimum.
Figure 6. Chemical structures of triterpenes and steroids in O. gratissimum.
Plants 15 01662 g006
Figure 7. Chemical structures of fatty acids and esters in O. gratissimum.
Figure 7. Chemical structures of fatty acids and esters in O. gratissimum.
Plants 15 01662 g007
Figure 8. Chemical structures of alcohols in O. gratissimum.
Figure 8. Chemical structures of alcohols in O. gratissimum.
Plants 15 01662 g008
Figure 9. Chemical structures of ketones in O. gratissimum.
Figure 9. Chemical structures of ketones in O. gratissimum.
Plants 15 01662 g009
Figure 10. Chemical structures of Aldehydes in O. gratissimum.
Figure 10. Chemical structures of Aldehydes in O. gratissimum.
Plants 15 01662 g010
Figure 11. (A) Chemical structures of hydrocarbonated monoterpenes in O. gratissimum. (B) Chemical structures of hydrocarbonated monoterpenes in O. gratissimum.
Figure 11. (A) Chemical structures of hydrocarbonated monoterpenes in O. gratissimum. (B) Chemical structures of hydrocarbonated monoterpenes in O. gratissimum.
Plants 15 01662 g011
Figure 12. Chemical structures of oxygenated monoterpenes in O. gratissimum.
Figure 12. Chemical structures of oxygenated monoterpenes in O. gratissimum.
Plants 15 01662 g012
Figure 13. Chemical structures of hydrocarbonated sesquiterpenes in O. gratissimum.
Figure 13. Chemical structures of hydrocarbonated sesquiterpenes in O. gratissimum.
Plants 15 01662 g013
Figure 14. Chemical structures of oxygenated sesquiterpenes in O. gratissimum.
Figure 14. Chemical structures of oxygenated sesquiterpenes in O. gratissimum.
Plants 15 01662 g014
Figure 15. Comprehensive molecular mechanism of the pharmacological actions of O. gratissimum. Abbreviations: Ach—Acetylcholine; PGE2—prostagladins E2; COX—cyclooxygenase; PGHS—prostaglandin H; L-1—lipoxygenase; PGE—prostagladins; IL-1β—interleukin 1-β; IL-6—interleukin-6; IL-1α—interleukin 1-α; TP53—tumour protein p53; BAX—X protein gene; BAK—BCL2 Antagonist/Killer 1; TNF-α—tumour necrosis factor-α; BCL-2—B-cell lymphoma-2; MMP—matrix metalloproteases; SOD—Superoxide dismutase; CAT—Catalase; BDNF—brain-derived neurotrophic factor; NRF-2—nuclear factor erythroid 2-FVGF-related factor-2; HO-1—Heme oxygenase-1; NGF—Nerve growth factor; ATP—Adenosine triphosphate; AGE—advanced glycation end products; BP—blood pressure; HR—heart rate; and DNA—deoxyribonucleic acid. Figure created using BioRender.com.
Figure 15. Comprehensive molecular mechanism of the pharmacological actions of O. gratissimum. Abbreviations: Ach—Acetylcholine; PGE2—prostagladins E2; COX—cyclooxygenase; PGHS—prostaglandin H; L-1—lipoxygenase; PGE—prostagladins; IL-1β—interleukin 1-β; IL-6—interleukin-6; IL-1α—interleukin 1-α; TP53—tumour protein p53; BAX—X protein gene; BAK—BCL2 Antagonist/Killer 1; TNF-α—tumour necrosis factor-α; BCL-2—B-cell lymphoma-2; MMP—matrix metalloproteases; SOD—Superoxide dismutase; CAT—Catalase; BDNF—brain-derived neurotrophic factor; NRF-2—nuclear factor erythroid 2-FVGF-related factor-2; HO-1—Heme oxygenase-1; NGF—Nerve growth factor; ATP—Adenosine triphosphate; AGE—advanced glycation end products; BP—blood pressure; HR—heart rate; and DNA—deoxyribonucleic acid. Figure created using BioRender.com.
Plants 15 01662 g015
Figure 16. Overview of molecular mechanisms of cognitive enhancement of O. gratissimum. Abbreviations: Ach—Acetylcholine; IL-1β—interleukin 1-β; IL-6—interleukin-6; IL-1α—interleukin 1-α; TP53—tumour protein p53; BAX—X protein gene; BAK—BCL2 Antagonist/Killer 1; TNF-α—tumour necrosis factor-α; BCL-2—derived neurotrophic factor; NRF-2—nuclear factor erythroid 2-related factor-2; HO-1—Heme oxygenase-1; NGF—Nerve growth factor; ATP—Adenosine triphosphate; AGE—advanced glycation end products; BP—blood pressure; HR—heart rate; and DNA—deoxyribonucleic acid. Figure created using BioRender.com.
Figure 16. Overview of molecular mechanisms of cognitive enhancement of O. gratissimum. Abbreviations: Ach—Acetylcholine; IL-1β—interleukin 1-β; IL-6—interleukin-6; IL-1α—interleukin 1-α; TP53—tumour protein p53; BAX—X protein gene; BAK—BCL2 Antagonist/Killer 1; TNF-α—tumour necrosis factor-α; BCL-2—derived neurotrophic factor; NRF-2—nuclear factor erythroid 2-related factor-2; HO-1—Heme oxygenase-1; NGF—Nerve growth factor; ATP—Adenosine triphosphate; AGE—advanced glycation end products; BP—blood pressure; HR—heart rate; and DNA—deoxyribonucleic acid. Figure created using BioRender.com.
Plants 15 01662 g016
Figure 17. NF-kB activation as a target for O. gratissimum eugenol and flavonoids. Cell stress, inflammation mediators, and growth factors. TNF-α, IL-1, and IL-6 activate NF-κB. Additionally, bioactive compounds, eugenol and flavonoids, are shown to inhibit the activity of IKK-y, α and β, which subsequently leads to suppression of the NF-kB activation, and activate immune response towards inflammatory cell stress. Inhibition is represented by the red line. Abbreviations: IL-1β—interleukin 1-β; IL-6—interleukin-6; IL-1α—interleukin 1-α; TNF-α—tumour necrosis factor-α; Nuclear factor kappa B (NF-Kb); inhibitory molecules of the kinase (IKK). Figure created using BioRender.com.
Figure 17. NF-kB activation as a target for O. gratissimum eugenol and flavonoids. Cell stress, inflammation mediators, and growth factors. TNF-α, IL-1, and IL-6 activate NF-κB. Additionally, bioactive compounds, eugenol and flavonoids, are shown to inhibit the activity of IKK-y, α and β, which subsequently leads to suppression of the NF-kB activation, and activate immune response towards inflammatory cell stress. Inhibition is represented by the red line. Abbreviations: IL-1β—interleukin 1-β; IL-6—interleukin-6; IL-1α—interleukin 1-α; TNF-α—tumour necrosis factor-α; Nuclear factor kappa B (NF-Kb); inhibitory molecules of the kinase (IKK). Figure created using BioRender.com.
Plants 15 01662 g017
Figure 18. Mechanisms of action for hepatoprotective effects of O. gratissimum. Abbreviations: transaminase (AST); alanine transaminase (ALT); alkaline phosphatase (ALP); total bilirubin (TB); reactive oxidative stress (ROS); IL-1β—interleukin 1-β; IL-6—interleukin-6; TNF-α—tumour necrosis factor-α; 70-kilodalton heat shock protein (HSP70); Inducible Nitric Oxide Synthase (iNOS); matrix metalloproteinase-9 (MMP-9); phosphorylated ERK (p/ERK1); nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB). Figure created using BioRender.com.
Figure 18. Mechanisms of action for hepatoprotective effects of O. gratissimum. Abbreviations: transaminase (AST); alanine transaminase (ALT); alkaline phosphatase (ALP); total bilirubin (TB); reactive oxidative stress (ROS); IL-1β—interleukin 1-β; IL-6—interleukin-6; TNF-α—tumour necrosis factor-α; 70-kilodalton heat shock protein (HSP70); Inducible Nitric Oxide Synthase (iNOS); matrix metalloproteinase-9 (MMP-9); phosphorylated ERK (p/ERK1); nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB). Figure created using BioRender.com.
Plants 15 01662 g018
Table 2. Pharmacological activities of O. gratissimum from recent studies.
Table 2. Pharmacological activities of O. gratissimum from recent studies.
No.Pharmacological ActivityPlant Part UsedExtract CompoundDosage (Experimental Usage)Type of StudyMethods and Biological Models (Assays)Findings/OutcomesReferences
1.AntibacterialLeavesAqueous,
n-Hexane and ethanol
100 mg/mLIn vivoEscherichia coli, Salmonella typhi, Proteus vulgaris, Shigella flexneri, Citrobacter freundi, Morganella morganii bacteria were subjected to disc diffusion and agar well diffusionThe ethanol of O. gratissimum exhibited strong inhibition properties against E.coli.[85]
2.Antibacterial: MicrobialLeavesAqueous and 70% ethanol100 mg/mL of extractIn vitro(Vibrio cholerae strains (C6123, E7919, and R1995);
Deoxycholate agar and nutrient agar
Extracts exhibited antibacterial activities against Vibrio strains through the augmentation of Vitamin C of O. gratissimum. Moreover, the ethanolic extract inhibited the Vibrio species better compared to the aqueous extract.[96]
3.Antibacterial: FungalLeaves and branches70% ethanol512 µg mL−1 of extractIn vivoEscherichia coli, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, Enterococcus faecalis, and Proteus mirabilis were subjected to agar well diffusion and Disc diffusionFungus, Nigrospora oryzae UILRZ1, extracted from the DNA fragment ITS1 and ITS4 primer pairs, of O. gratissimum leaves and branches, showed increased antibacterial activity against the chosen bacterial species, particularly affecting Staphylococcus aureus.[49]
4.AntidiabeticLeavesAqueous0–10 mg/mLIn vitroFRAP, DPPH, and iron chelatingO. gratissimum extracts exhibited higher antioxidants output, FRAP, DPPH, indicating potential to reduce and modulate oxidation agents.[22]
5.Anti-inflammationLeavesNitric acid and hydrochloric acid2 g of the extract sampleIn vivoMale Wistar rats treated with inclusion of O. gratissimum extracts, conducted an ELISA assayWistar rats administered with O. gratissimum extract observed a significant increase in serum immunoglobulins G & M, showing improved signs of anti-inflammatory activities.[29]
6.AntioxidantsLeavesMethanol200, 400 and 600 mg/kg of extractIn vivoMale Wistar rats, induced with benign prostatic hyperplasia and administered with subcutaneous testosterone propionateExtracts that the Wistar rats were treated with demonstrated effects in increasing catalase activity and declining malondialdehyde levels, demonstrating O. gratissimum extracts’ ability to reduce oxidative stress and improve antioxidant defence mechanisms.[108]
7.AntioxidantsLeaves and rootsAqueous200 µL, 40 µL and 160 µLIn vitroO. gratissimum supplemented to growth nutrition under photosynthetic photon flux density at 150 µmol m−2 s−1O. gratissimum exposure to the UV-A radiation enhances antioxidant activities when measured under DPPH, FRAP and oxygen radical absorption capacity.[113]
8.AntioxidantsLeavesAqueous3–21 w/v%In vitroDPPH, nitric oxide, reducing power, and total antioxidant capacityHot aqueous extract has an impact in increasing the antioxidant properties of O. gratissimum and reducing resistance (p ˂ 0.05).[79]
9.AntioxidantsLeavesAqueous0–2.5 mg/mLIn vitroCarbohydrate-hydrolysing enzymes inhibitory assaysO. gratissimum extracts demonstrated higher inhibition of α-amylase (IC50: 0.47 mg/mL), and slight inhibition to the α-glucosidase (IC50: 9.09 µg/mL).[22]
10.Anti-repellentWhole plantessential oils1 µL analysed in GC-MSIn vivoCallosobruchus chinensis subjected to the fumigant bioassay methodExposure to the O. gratissimum extract demonstrated 100% toxicity and death rate of Callosobruchus chinensis and healthy growth of grains, signifying that O. gratissimum has anti-insectidal properties.[127]
11.Anti-repellentStemEthanol, acetone and aqueous2 g of extractIn vivoMosquito Larvae subjected to larvicidal bioassay and mosquitocidal bioassayO. gratissimum ethanol extract repelled 37.5% of mosquitoes and demonstrated 80% larvicidal effects on mosquitoes.[30]
12.Anti-repellent: InsecticidalWhole plant--In vitroApolygus lucorum were subjected to a choice assayStudy results demonstrate that O. gratissimum tea plantation reduced the abundance of insects A. lucorum, and that natural smell of plant flowers acted as repellents to the insects.[58]
13.HypolipidemicLeavesMethanol200, 400 and 600 mg/kg of extractIn vivoMale Wistar rats, induced with benign prostatic hyperplasia: Evaluated for total cholesterol using total oxidase, glycerol phosphate oxidase, and low-density lipoprotein cholesterolO. gratissimum-treated specimen lipid profile reduced triglycerides, lowered levels of density lipoprotein cholesterol and increased levels of high-density lipoprotein cholesterol; these findings demonstrate extract-ability for modulate lipid profiles.[108]
14.Nootropic/Cognitive enhancement propertiesLeavesEthanol150–300 mg/kg, p.oIn vivoMale Wister rats occluded the middle cerebral artery and underwent reperfusionStudy revealed that O. gratissimum ethanol extract has neuroprotective effects by increasing cerebral infarction volume and lipid peroxidation, and decreasing glutathione peroxidase and superoxide dismutase in the brain.[129]
15.Anti-convulsantLeavesEthanol300 mg/kgIn vivoAlbino rats,Albino rats treated with O. gratissimum extract showed and were observed to have isoniazid-induced convulsions compared to the control group of Albino rats, which were treated with picrooxin.[130]
16.OrganolepticLeavesHexane-In vitroHydro-distillation methodThe sensory evaluation of the study discovered that O. gratissimum concoction spice was significantly preferred due to taste, texture, colour, and flavour, with the acceptability proportion significantly differing from products such as mayonnaise and salad cream.[47]
17.OrganolepticLeaves--In vitroFood physio-biochemical analysisThe study found that the acceptability of the O. gratissimum extract protein biscuit had the highest level of sensory satisfaction, with 60–70% of participants replacing wheat flour biscuit with O. gratissimum[68]
18.OrganolepticLeaves--In vitroHedonic testThe study discovered that 50% of participants preferred the O. gratissimum flavoured recipes and sauces compared to other ingredients[131]
19.Toxicity/CorrosionLeavesEthanol300 mL of 15 g extractIn vitroWater-in-diesel emulsions, a mild steel engine, and conducting gravimetric and surface probe experimentsO. gratissimum extract demonstrated a 91.5% effectiveness in preventing corrosion of mild steel when used in a water–diesel emulsion.[132]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Maphetu, N.; Unuofin, J.O.; Oladipo, A.O.; Lebelo, S.L. Ocimum gratissimum: Chemical Composition, Phytochemical Properties, Antioxidants, and Pharmacological Activities: A Review. Plants 2026, 15, 1662. https://doi.org/10.3390/plants15111662

AMA Style

Maphetu N, Unuofin JO, Oladipo AO, Lebelo SL. Ocimum gratissimum: Chemical Composition, Phytochemical Properties, Antioxidants, and Pharmacological Activities: A Review. Plants. 2026; 15(11):1662. https://doi.org/10.3390/plants15111662

Chicago/Turabian Style

Maphetu, Nhlanhla, Jeremiah O. Unuofin, Adewale O. Oladipo, and Sogolo L. Lebelo. 2026. "Ocimum gratissimum: Chemical Composition, Phytochemical Properties, Antioxidants, and Pharmacological Activities: A Review" Plants 15, no. 11: 1662. https://doi.org/10.3390/plants15111662

APA Style

Maphetu, N., Unuofin, J. O., Oladipo, A. O., & Lebelo, S. L. (2026). Ocimum gratissimum: Chemical Composition, Phytochemical Properties, Antioxidants, and Pharmacological Activities: A Review. Plants, 15(11), 1662. https://doi.org/10.3390/plants15111662

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop